STABILIZATION OF EXTENDED DIFFUSE OPTICAL SPECTROSCOPY MEASUREMENTS ON IN VIVO HUMAN SKELETAL MUSCLE DURING DYNAMIC EXERCISE by Henry, Brad A.
University of Kentucky 
UKnowledge 
Theses and Dissertations--Biomedical 
Engineering Biomedical Engineering 
2014 
STABILIZATION OF EXTENDED DIFFUSE OPTICAL 
SPECTROSCOPY MEASUREMENTS ON IN VIVO HUMAN 
SKELETAL MUSCLE DURING DYNAMIC EXERCISE 
Brad A. Henry 
University of Kentucky, bahe224@g.uky.edu 
Right click to open a feedback form in a new tab to let us know how this document benefits you. 
Recommended Citation 
Henry, Brad A., "STABILIZATION OF EXTENDED DIFFUSE OPTICAL SPECTROSCOPY MEASUREMENTS ON 
IN VIVO HUMAN SKELETAL MUSCLE DURING DYNAMIC EXERCISE" (2014). Theses and Dissertations--
Biomedical Engineering. 22. 
https://uknowledge.uky.edu/cbme_etds/22 
This Master's Thesis is brought to you for free and open access by the Biomedical Engineering at UKnowledge. It has 
been accepted for inclusion in Theses and Dissertations--Biomedical Engineering by an authorized administrator of 
UKnowledge. For more information, please contact UKnowledge@lsv.uky.edu. 
STUDENT AGREEMENT: 
I represent that my thesis or dissertation and abstract are my original work. Proper attribution 
has been given to all outside sources. I understand that I am solely responsible for obtaining 
any needed copyright permissions. I have obtained needed written permission statement(s) 
from the owner(s) of each third-party copyrighted matter to be included in my work, allowing 
electronic distribution (if such use is not permitted by the fair use doctrine) which will be 
submitted to UKnowledge as Additional File. 
I hereby grant to The University of Kentucky and its agents the irrevocable, non-exclusive, and 
royalty-free license to archive and make accessible my work in whole or in part in all forms of 
media, now or hereafter known. I agree that the document mentioned above may be made 
available immediately for worldwide access unless an embargo applies. 
I retain all other ownership rights to the copyright of my work. I also retain the right to use in 
future works (such as articles or books) all or part of my work. I understand that I am free to 
register the copyright to my work. 
REVIEW, APPROVAL AND ACCEPTANCE 
The document mentioned above has been reviewed and accepted by the student’s advisor, on 
behalf of the advisory committee, and by the Director of Graduate Studies (DGS), on behalf of 
the program; we verify that this is the final, approved version of the student’s thesis including all 
changes required by the advisory committee. The undersigned agree to abide by the statements 
above. 
Brad A. Henry, Student 
Dr. Guoqiang Yu, Major Professor 
Dr. Abhijit Patwardhan, Director of Graduate Studies 
STABILIZATION OF EXTENDED DIFFUSE OPTICAL SPECTROSCOPY 
MEASUREMENTS ON IN VIVO HUMAN SKELETAL MUSCLE DURING 
DYNAMIC EXERCISE 
THESIS 
A thesis submitted in partial fulfillment of the requirements for the degree 
Master of Science in Biomedical Engineering in the College of Engineering at 
the University of Kentucky 
By 
Brad Henry 
Lexington, Kentucky 
Director:  Dr. Guoqiang Yu, Associate Professor of Biomedical Engineering 
Lexington, Kentucky 
2014 
Copyright © Brad Henry 2014 
 
 
 
 
 
 
ABSTRACT OF THESIS 
 
 
 
 
STABILIZATION OF EXTENDED DIFFUSE OPTICAL SPECTROSCOPY 
MEASUREMENTS ON IN VIVO HUMAN SKELETAL MUSCLE DURING 
DYNAMIC EXERCISE 
 
This research investigates various applications of diffuse correlation spectroscopy 
(DCS) on in-vivo human muscle tissue, both at rest and during dynamic exercise. 
Previously suspected muscle tissue relative blood flow (rBF) baseline shift during 
extended measurement with DCS and DCS-Near infrared spectroscopy (NIRS) 
hybrid optical systems are verified, quantified, and resolved by redesign of optical 
probe and alteration in optical probe attachment methodology during 40 minute 
supine bed rest baseline measurements.  
 
We then translate previously developed occlusion techniques, whereby rBF and 
relative oxygen consumption rV̇O2 are calibrated to initial resting absolute values 
by use of a venous occlusion (VO) and arterial occlusion (AO) protocol, 
respectively, to the lower leg (gastrocnemius) and these blood flows are cross 
validated at rest by strain gauge venous plethysmography (SGVP). Methods used 
to continuously observe 0.5Hz, 30% maximum voluntary isometric contraction 
(MVIC) plantar flexion exercise via dynamometer are adapted for our hybrid 
DCS-Imagent diffuse optical flow-oximeter in the medial gastrocnemius. We 
obtain healthy control muscle tissue hemodynamic profiles for key parameters 
BF, V̇O2, oxygen saturation (StO2), deoxyhemoglobin, oxyhemoglobin, and total 
hemoglobin concentrations ([Hb], [HbO2], and THC respectively), as well as 
systemic mean arterial pressure (MAP) and pulse rate (PR), at rest, during 
VO/AO, during dynamic exercise and during 15 minute recovery periods.  
 
Next, we began investigation of muscle tissue hemodynamic disease states by 
performing a feasibility pilot study using limited numbers of controls and 
 
 
peripheral arterial disease (PAD) patients using the translated methods/techniques 
to determine the ability of our technology to assess differences in these 
populations. 
 
 
KEYWORDS: Diffuse correlation spectroscopy; near-infrared spectroscopy;        
blood flow; oxygen consumption rate; skeletal muscle;  
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CHAPTER 1: INTRODUCTION AND BACKGROUND 
 
1.1 Microvascular Hemodynamics and Metabolism in Muscle 
The delivery of metabolic nutrients, oxygen, and removal of waste molecules 
is of paramount importance for the maintenance of healthy tissue.  As such, the 
network of vessels, and the regulation of flow through those vessels have reached 
a phenomenally sensitive status with respect to nervous, mechanical, and 
metabolic stimulation.  The small vessels (arterioles, capillaries, and venules) are 
of a particular interest since it is in this part of the vasculature that large scale 
exchange of O2 molecules occurs and where many of the regulatory systems take 
their effect, as in the resistive elements of the pre-capillary arterioles.  By 
observing the hemodynamics, that is the blood flow, oxygenation status, and 
tissue oxygen consumption rate parameters, of a tissue one can better understand 
the extent to which the microvasculature is functioning and therefore how well the 
homeostatic environment of the tissue is responding to functional demands.  Of 
particular interest is the study of the hemodynamics of the skeletal muscle. 
Skeletal muscle, by virtue of both its sheer mass of body composition (40-50% 
by mass)[1] and its necessity to everyday life, is a system whose function is 
critical to maintaining a healthy, active lifestyle and whose function has been 
strongly correlated to survival/life expectancy in various disease conditions[2].  
Skeletal muscle is involved in every voluntary motion and in the function of the 
muscles that operate the chest cavity during breathing.  Disorders in skeletal 
muscle function, whether by metabolic impairment, insufficient perfusion, or 
contractile malfunction range in severity from decreased activity, pain and limited 
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mobility, such as in peripheral arterial disease (PAD), to loss of limb and tissue 
ulcers, as experienced in diabetes and bedridden patients, to terminal wasting 
diseases, as in muscular dystrophy and age related sarcopenia[2].  It is estimated 
that about 8 million cases of PAD currently exist in the U.S. alone and that 12-
20% of people over the age of 60 suffer from the disease[3].  These numbers are 
expected to swell with the increasingly aged population and the highly prevalent 
risk factors (smoking, obesity, diabetes, and high cholesterol) that contribute to 
the disease.  The costs associated with patient care for PAD and other muscle 
wasting diseases will likewise rise substantially[4]. 
In addition to the various disease states which affect muscle, the function of 
muscle is of great interest to sports and exercise medicine.  It can be difficult to 
assess functionality in terms other than gross power output or morphology.  The 
perfusion and oxygenation of muscle tissue has direct implications on the ability 
of that muscle to perform[5].  Different activities and types of exercise/athletics 
exert different forms of hemodynamic response and these can be characterized to 
improve the responsiveness of a training regimen or to tailor a training toward a 
specific functional state (high endurance via sustained oxygen saturation vs. 
hypertrophic increases in muscle mass for power lifting)[6]. 
Despite the imminent importance of the skeletal muscle system and the 
volume of disease populations suffering from muscular disorders, there are 
relatively few ways to noninvasively assess the performance of muscle tissue in 
vivo, especially with respect to local blood perfusion and tissue oxygenation[7].   
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1.2 Tissue Blood Oxygenation Measurement 
Traditional measurement techniques for determining the oxygenation of 
blood/tissue and thus the metabolic activity of the tissue relied on indirect 
methods such as Douglas bag spirometry or respiratory gas analysis, which 
measure oxygen concentration decreases/carbon dioxide increases in expired 
air[8].  This technique only measured the global metabolic rate and would only be 
used to indicate net gas exchange at time points for only as many gas bags as are 
feasibly available to be implemented as a single measurement may be taken with 
a particular bag and thus serial measurements require multiple bags, thus greatly 
limiting sampling rates and specificity of the measurement.  Spirometry is then 
unable to localize oxygen consumption rate measurements in active muscles and 
cannot then be used in a diagnostic or evaluative manner for specific organ 
systems.  More recently, blood oxygen and chemical analysis have been used to 
sample tissue metabolism but this involves invasive catheterization of the vessels 
and lacks an ability to make continuous measurements[9].  These techniques also 
share the weakness of being unable to localize the oxygen consumption rate to a 
specific muscle compartment since the vessels catheterized are typically large 
arteries and veins at opposing ends of the limb.  Functional MRI (fMRI) has also 
been used to track changes in blood oxygenation in the tissue 
microvasculature[10].  The functional MRI imaging allows continuous and 
noninvasive monitoring of tissue oxygenation with high spatial resolution in deep 
tissues.  Temporal resolution of such measurements is limited with BOLD (blood 
oxygen level dependent) measurements requiring as much as 12-18 seconds to 
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produce a measurement [11, 12].  fMRI and other radio-imaging techniques will 
be discussed further in Chapter 1.4 as they are also used to assess tissue blood 
flow.  Optical methods of measuring local tissue oxygenation have been 
developed that use near infrared (NIR) light to measure the concentration of 
oxygen binding chromophores; the specifics of which are discussed more 
thoroughly in Chapter 1.3. 
1.3  Near-infrared Spectroscopy (NIRS) for Tissue Blood Oxygenation     
Measurement 
 
Over the last few decades, near-infrared (NIR) tissue oximetry has gained 
wide acceptance and been implemented in a broad range of applications, both 
clinically and in academia[12-20].  The noninvasive and exquisitely sensitive 
detection of tissue oxygenation, using relatively inexpensive and portable 
equipment with fast acquisition times has revolutionized deep tissue metabolic 
observation.  NIR is made possible by the existence of a low absorbance band 
(700 to 900 nm) of light in tissue.  Within this band, the dominant absorbers in 
tissue are oxy-hemoglobin, deoxy-hemoglobin, fat, and water (Figure 1).   
Of the aforementioned absorbers, the primary two to change dynamically are 
the oxygen binding blood metalloproteins: oxy- and deoxy-hemoglobin, denoted 
HbO2 and Hb respectively.   Thus the majority of light absorption changes in this 
band are attributable to the blood chromophores and these two are clearly 
spectrally distinguishable (Figure 1)[15, 21].   
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Figure 1. Absorption Spectra and the NIR Optical Window  
The aborbances of HbO2 and Hb are very similar at 800 nm thus this wavelength should be 
avoided when using NIR light to detect tissue absorption.  Other absorbers such as water and lipid 
(fat) have minimal absorption between 700 and 900 nm thus sources in this range should have 
maximal penetration depths.   
 
As NIR photons move through tissue, they are scattered at a much greater rate 
than they are absorbed creating a diffusive profile of movement through the tissue 
medium in which some photons are eventually diffused back to the tissue surface 
interface.  This process is very complex and has been given a thorough treatment 
elsewhere, readers are invited to examine literature[15, 22].  The degree to which 
a media will absorb light is characterized by its absorption coefficient (μa), and 
the degree to which photons tend to scatter is likewise characterized by its 
reduced scattering coefficient (μs’), both with the unit of per centimeter (cm-1).  In 
NIRS it has been established that by illuminating tissue with two or more 
wavelengths of light in the NIR optical window band, measuring the changes in 
detected light intensity a certain distance away from the source, and knowing the 
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extinction coefficients of the involved absorbers, the changes in absorber 
concentration can be quantified[12, 15, 17, 22-24].  This relationship, including a 
modification that adjusts for multiple scattering events, is known as the modified 
Beer-Lambert Law[15, 21] and will be discussed in detail later.  The use of 
different source illumination modalities, as well as the detection of intensity 
changes at multiple source-detector (S-D) separations allows for the calculation of 
absolute absorbers’ concentrations (e.g., [HbO2] and [Hb]) in tissue[25]).  These 
absolute measurements may then be combined to derive total hemoglobin 
concentration (THC= [HbO2] + [Hb]), and tissue blood oxygen saturation (StO2 = 
[HbO2]/THC ×100%). 
The three categories of NIR oximeter are continuous wave (CW), frequency 
domain (FD), and time domain (TD) systems whose categorization can be made 
by illumination pattern (Figure 2).   
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Figure 2. NIRS Illumination Modalities 
The CW system (panel a) employs a continuous source illumination in which the intensity changes 
can be used to calculate absorber concentration changes.  FD system (panel b) modulates the line 
with sine waves and the changes in signal amplitude and phase allow for calculation of absolute μa 
and μs.  These are then used to calculate absolute concentrations of absorber molecules[24].  The 
TD system (panel c) injects a defined short pulse of light into the tissue and detects the change in 
amplitude of the pulse as well as its shape.  These two qualities can be used to determine the 
values of the absolute chromophore concentrations[19].  
 
CW oximeter is the simplest to operate and analyze, as well as the most 
inexpensive, but can only yield relative changes in hemoglobin concentrations.  
The other two systems can produce absolute absorber concentrations but are more 
expensive with an additional layer of data analysis.  The TD system, requiring a 
larger amount of time to measure intensity pulse width, thus has a lower sampling 
time than the other two systems.  Our lab makes use of a commercial FD-NIRS 
oximeter (Imagent, ISS Inc., IL), whose details will be discussed in Chapter 2.1, 
to detect absolute values of [Hb] and [HbO2] as it has the capability of detecting 
absolute tissue oxygenation with temporal resolutions ranging from 0.5 to 100 Hz, 
depending on noise tolerances. 
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1.4 Tissue Blood Flow Measurements 
Using NIRS to measure blood flow is a relatively recent addition to the 
repertoire of noninvasive optical measurements.  Previous flow measurements 
relied on invasive catheterization of the large vessels with pressure transducers.  
In addition to the invasiveness of this technique, it limits measurement to the 
vessels smaller than the catheter.  More advanced local clearance techniques such 
as 133-Xe washouts and Indocyanine green dyes (ICG) make use of indicator 
dyes and their clearance rates to quantify blood flow through the microvascular 
beds.  However, these techniques are still invasive and some may also employ 
radioactive materials.  Furthermore, due to recycling of the dye, continuous or 
quickly repeated measurements are impossible[26].   
Noninvasive measurements of flow historically include strain gauge venous 
plethysmography (SGVP), a technique in which pressure in excess of diastolic 
(venous return) pressure is applied to the limb, preventing blood from leaving the 
compartment.  A strain gauge is used to measure the rate of change in limb 
circumference and thereby calculate the volume of inflowing blood.  This 
measurement is, by its nature, disturbing to flow and cannot be performed in rapid 
succession[12, 26, 27].  This measurement method is also only useful for 
assessing whole limb flow and so cannot be used to distinguish local working 
muscle group blood flow from passive muscle flow.  SGVP will be discussed 
more thoroughly in Chapter 4 and the Appendix where it was used as part of a 
protocol, for comparison/validation purposes.   
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More advanced noninvasive flowmetry has been developed using magnetic 
imaging techniques or PET.  fMRI and PET stand out as effective methods for 
assessing the combined parameters of tissue oxygenation, blood flow, or 
phosphate metabolites.  Temporal resolution for these is fair (~0.1 Hz for arterial 
spin labeled fMRI and 0.025 Hz for PET), though lacking when compared to 
other techniques such as Doppler Ultrasound, Laser Doppler, and NIR diffuse 
correlation spectroscopy (DCS)[11, 28].  The spatial resolution to both is fine, 
ranging from 100-250 μm for fMRI and 1.5 mm for PET[11, 29].  Whether the 
temporal sensitivity loss is worth the spatial gain is dependent on the purpose of 
the study.  The major disadvantages of fMRI and related imaging technologies 
have always been the cost, the degree of difficulty in analysis of acquired signals, 
and the requirement that patients be confined to an MRI tube which severely 
limits the potential exercising applications of the technology.  Additionally, PET 
is still reliant on the use of radioactive elements.  Some of these methods, ASL 
MRI at least, may have limited use in low blood flow scenarios which makes it 
non optimal for assessing resting or recovery values of blood flow[28]. 
Doppler ultrasound (DU) has proven to be a reliable technique for assessing 
large vessel flow with a high temporal resolution and deep tissue penetration.  As 
its name implies, ultrasound relies of the insonation of the tissue with high 
frequency sound waves[26].  However, the technology is limited in exercise 
protocols by the necessity of maintaining a set insonation angle and good 
insonator/receiver contact. The major weakness inherent to DU flowmetry is in 
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that only larger blood vessels may be observed.  This means that only the supply 
vessel flow and not the exchange vessel flows can be observed.   
Overall, each of these flowmetries has advantages or disadvantages in terms of 
cost, sensitivity, or ease of operation.  However, none of them meet the demand of 
making noninvasive, continuous and dynamic measurements, with high 
sensitivity, high temporal resolution, in deep tissue microvasculature.  Recently 
developed NIR DCS-based technologies showed the potential to meet these 
requirements (see Chapter 1.5)[12, 15, 30-32]. 
1.5 NIR Diffuse Correlation Spectroscopy (DCS) for Microvascular Blood 
Flow Measurement 
 
 
NIR Diffuse correlation spectroscopy (DCS) is a method of assessing 
microvascular perfusion that has been developed over the last twenty years.  DCS 
incorporates the same NIR light band as NIRS but applies this photon 
illumination and detection scheme to observe a distinctly different system.  
Instead of observing chromophore concentrations, this system monitors light 
speckle fluctuation at the tissue surface.  Speckles are discrete regions of photon 
intensity generated by the effects of moving scatterers in highly scattering media 
on photons traveling through it, and which can be produced by illuminating tissue 
with a long coherence CW laser[15, 22].  The presence of scattering bodies under 
motion, which for biological tissues is predominantly limited to erythrocytes in 
the blood, causes these speckles to fluctuate rapidly.   The multiple scattering of 
photons by moving bodies, each of which imparts a random vector and phase shift 
to the photons producing, when summed, a temporally fluctuating interference 
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pattern at the interface[15, 22].  By measuring the intensity changes of a single 
speckle using a single mode optical fiber connected to a single photon counting 
photodetector and correlating them using an autocorrelator, these changes can be 
quantified to assess the average flow of moving scatterers (red blood cells) within 
the photon path and used as an index of blood flow.  By normalizing the blood 
flow index to its initial resting baseline value, the relative blood flow (rBF) can be 
obtained[15, 20, 33].  The theoretical specifics of how speckle intensity 
fluctuations are used to calculate blood flow index and rBF will be left to the 
discussion of methods in Chapter 2. 
The advantage of this system is that it possesses a high temporal resolution (up 
to 100 Hz), a reliable tissue penetration depth of up to ~1.5 cm (deep enough to 
observe superficial muscle), noninvasiveness, portability, and low running costs 
of optical spectroscopy[34].  The ability to noninvasively measure microvascular 
blood flow with high temporal resolution is unique to the DCS and makes it of 
particular use in clinical application to evaluating deep tissue perfusion.  This 
technology has been validated against several accepted techniques including Xe-
CT, arterial-spin-labeled MRI, Doppler ultrasound, power Doppler ultrasound, 
and fluorescent microspheres[16, 28, 35-40].  The tissues observed, as previously 
mentioned, also range broadly and include human/mouse brains, head/neck 
tumors, breast, and skeletal muscle[16, 28, 31, 36-43].  The recent innovation of a 
novel gating algorithm in our laboratory has allowed the use of DCS with 
minimal motion artifacts, such as those prevalent during muscle contractions in 
previous studies[16, 31, 44].  Also, a commercial tissue oximeter has been 
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employed in conjunction with DCS to create a hybrid diffuse optical flow-
oximeter (see Chapter 1.6)[8, 15, 31, 32]. 
1.6 Hybrid Diffuse Optical Spectroscopies for Measurements of Both 
Tissue Blood Flow and Oxygenation 
 
 
In the past our lab had developed two types of hybrid instruments for 
simultaneous microvascular blood flow and oxygenation measurements: a dual-
wavelength DCS (CW)[45-52] flow-oximeter and a combined DCS/FD-NIRS 
(Imagent) flow-oximeter[31, 32, 41, 53]. By using a second wavelength long 
coherence source laser and alternately illuminating the tissue with 2 wavelengths 
it is possible to simultaneously collect both relative changes in tissue oxygenation 
(Δ[Hb], Δ[HbO2], and ΔTHC), as discussed in Chapter 1.3, and rBF as discussed 
in Chapter 1.5[15].  CW-DCS flow-oximetry is relatively inexpensive and allows 
for continuous quantification of the real time changes in microvascular 
hemodynamics with a locality, sensitivity, and temporal resolution unavailable to 
other systems.    
Combination of an FD-NIRS and DCS requires the integration of two separate 
sets of hardware and their associated operating software.  This additional layer of 
complexity is largely offset by the gain of absolute tissue absorption and reduced 
scattering coefficients, which were previously assumed for the sake of DCS 
measurements.  Most importantly, this system has the advantage of determining 
[HbO2], [Hb], THC, and StO2 in absolute units.   These are necessary to perform 
occlusion calibrations for initial values of absolute tissue blood flow (BF) in units 
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of ml blood*100ml tissue-1*min-1 and the derived oxygen consumption rate (V̇O2) 
in units of mlO2*100g-1*min-1[31, 53].     
This recently adopted hybrid FD-NIRS/DCS optical system, combined with 
finger plethysmography measurements of mean arterial pressure (MAP) and pulse 
rate, allows for the simultaneous collection of a suite of hemodynamic parameters 
which include relative/absolute blood flow (rBF/BF), relative/absolute oxygen 
consumption rate (rV̇O2/V̇O2), [Hb], [HbO2], THC, StO2, MAP, and pulse rate.  
All of these measurements are made continuously, noninvasively, and rapidly 
making hybrid diffuse optical measurements of unique benefit in evaluating tissue 
microvascular hemodynamics and metabolism. 
1.7 Baseline Stability of DCS Contact Blood Flow Measurement 
In previous studies performed on muscle tissue, we noted that blood flow 
index (αDB) exhibited an unexpected increase during prolonged measurements.  
Previous investigations revealed that no such trend in blood flow was observed 
during contact probe cerebral hemodynamics measurements[41] nor were they 
observed during preliminary measurements on gastrocnemius tissue using a 
noncontact probe (unpublished data). This eliminates immediately DCS hardware 
drift and effects of the source on the tissue since both the noncontact and contact 
probe use the same instrument. Given that muscle tissue and cerebral tissue have 
vastly different conditions (fixed skull geometry for the cerebral tissue, pliable 
muscle tissue with possible contractile motion/geometry artifact in the muscle, 
different autoregulatory innervations, etc.), it is possible that the tissues might 
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have differential responses associated with the measurement. We thus hypothesize 
that only factors related to the unique combination of muscle tissue and use of 
contact probe to measure it can be attributed to the baseline BF shift. Details for 
solving the problem of baseline BF shift can be found in Chapter 3. 
1.8 Measurement of Hemodynamic and Metabolic Profiles During 
Exercise in Gastrocnemius Muscle 
 
 
Eventually our research aims to examine patient populations which have 
diseases of muscle hemodynamics and metabolism. Many of these diseases 
preferentially affect the lower limbs.  This study then aimed at applying absolute 
calibration of continuous, relative, optical measurements during exercise to the 
lower limb (gastrocnemius).  Calibration of relative measurements consists of 
performing a series of occlusions in order to obtain initial resting baseline values 
for BF and V̇O2 that have been met with success in previous studies by this 
lab[32]. For the purposes of transferring the dynamic measurement methods in 
forearm, as described by Gurley et al [32] during handgrip exercise, to the lower 
limb, we decided to employ a plantar flexion exercise protocol with a fixed 
percentage (30%) maximum voluntary isometric contraction (MVIC) in healthy 
subjects.  This protocol would allow us to establish a complete 
hemodynamic/metabolic profile of typical responses to exercise in the lower limb. 
The protocol, detailed in Chapter 4.1 and 4.2, closely mirrored a study performed 
by Bauer et. al., giving this protocol some precedent in physiological 
literature[54].  Strain gauge venous occlusions were used to concurrently measure 
absolute limb BF in the gastrocnemius at resting baseline and post exercise in 
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order to assess the validity of our BF calibration and to examine the whole limb 
BF response to exercise in comparison to local tissue. 
1.9  Pilot Study on Peripheral Arterial Disease (PAD) 
Our major purpose in transferring continuous absolute measurement methods 
applied previously in the forearm to the gastrocnemius is to initiate investigation 
into the hemodynamic effects of PAD on lower limb muscles.  PAD is a vascular 
insufficiency in the lower limbs that results in an ever increasing difficulty in 
supplying the tissue with oxygen, particularly noticed during every day events 
such as walking or working on ones feet.  The disease is commonly found in 
patients who suffer from hypertension, diabetes mellitus, atherosclerosis, and 
smokers[55].  As the vascular integrity of the patients deteriorates, the symptoms 
of PAD worsen until the ischemia becomes severe enough to induce necrosis.  In 
this case the lower limbs, most often starting at the feet, begin to ulcerate 
producing wounds prone to infection and highly resistant to healing[3, 55-57].  
The muscle locality and compromise of both flow and oxygenation due to this 
disorder seemingly make hybrid flow-oximetry an ideal system with which to 
observe such a disorder.  
1.10 Thesis Organization 
This thesis is organized as follows. Chapter 2 introduces the methods and 
theory behind NIRS oximetry and DCS flowmetry, which are the predominant 
systems employed in this work.  The methods for calibrating relative blood flow 
using venous occlusion and relative oxygen consumption using arterial occlusion 
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are also described.  Lastly a brief discussion of data processing and statistical 
methods is made.   
Blood flow measurement stability on in-vivo muscle must first be established 
to confirm/remediate possible baseline blood flow elevations.  Thus a series of 
baseline DCS contact measurements are made to assess the long term stability of 
in-vivo relative flow, which are presented in Chapter 3.   
The diffuse optical techniques used to calibrate local absolute baseline values 
for blood flow and oxygen consumption rate and for continuous monitoring 
related hemodynamic responses during exercise have thus far only been applied to 
examine hemodynamics of the forearm flexor muscles.  This muscle group is of 
limited interest in the investigation of some perfusion disorders in lower limb and 
the broadening of ranges of muscle groups which we may assess during exercise 
is important for bringing this technology to clinical relevance.  Chapter 4 then 
describes a study performed to translate absolute calibration of relative 
hemodynamics and continuous exercise methods to the gastrocnemius.   
The ultimate goal of this research is to use hybrid diffuse optics clinically, 
applying them to patient populations (e.g., PAD) for eventual diagnoses and 
treatment monitoring. To this end, the final study of this thesis, Chapter 5, is a 
small pilot study designed to determine whether or not our methods and 
instrumentation is feasible to be used in patients with PAD at rest and during 
exercise. 
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At the end, Chapter 6 discusses the difficulties and methodological 
considerations that were involved with each of the studies herein, and summarizes 
results, conclusions and future perspectives.    
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CHAPTER 2:  DIFFUSE OPTICAL METHODS, INSTRUMENTATION 
AND DATA PROCESSING  
 
This chapter is devoted to discussion of the theories of diffuse optical 
flowmetry and oximetry and instrumentation used to make microvascular 
hemodynamic/metabolic measurement (Chapter 2.1 and 2.2).  It also introduces 
the methodology and theory of using venous and arterial occlusions to measure 
absolute tissue blood flow and oxygen consumption rate respectively (Chapter 2.3 
and 2.4).  These values are used to calibrate relative optical measurements.  Lastly 
a brief discussion of gating algorithm to reduce motion artifacts and data analysis 
methods will be made (Chapter 2.5). 
2.1 FD-NIRS Oximetry 
Absolute tissue oxygenation measurements are made using a commercial 4-
wavelength FD-NIRS instrument (Imagent, ISS Inc., IL).  The Imagent spatially 
resolved spectroscopy employs four, 110 MHz modulated sources at 690, 750, 
780 and 830 nm to probe tissue absorbance.  The source light is injected via 
multimode source fiber optic cables (diameter = 400 μm) at 4 S-D separations 
(2.0, 2.5, 3.0 and 3.5 cm) for all wavelengths.  After diffusing through the tissue, 
the light is collected via large diameter multimode fibers (diameter = 2.5 mm) and 
detected by a photomultiplier tube (PMT) which converts the detected photons 
into a voltage signal. 
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Figure 3. Probe Geometry and Photon Path 
The path of photon diffusion is characterized by an inverted “banana” shape region from the 
source to the detector, distance denoted ρ.  Note the random scatter vectors and semi-infinite 
geometry. Semi infinite refers to the existence of a single flat boundary condition in which 
photons only undergo transitional effects at the source/detector interface.  Additionally assumed is 
the homogeneity of this medium, which is a somewhat generous approximation of tissue. 
 
Since the light is frequency modulated, the detected intensity has a modulated 
light amplitude (AC signal), an average light intensity (DC signal), and a 
difference in time or phase (φ). 
The method of calculating the absolute scattering and absorbing coefficients of 
the tissue are based upon a photon diffusion equation [15, 30].  The equation, and 
details related to its derivation and solution may be found in the immediately 
preceding citations.  The results are that a linear relationship exists between the 
natural log of the AC signal, the natural log of the DC signal, and φ at different S-
D separations (r).  These linear relations can be fit and their slopes (denoted Sdc, 
Sac, Sφ) can be used to calculate the absolute μa and μs’ via the following 
equations[58]: 
    (1)   ( ) ( ) ( )dcdc'sadc2 KD,Inμ,μrSrdcln +=⋅
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        (2)  
   (3)  
    (4)  
     (5)  
    (6)  
Here, μa is absorption coefficient, μs’ is reduced scattering coefficient, D is the 
photon diffusion constant (υ/3μs’), υ is the speed of light in the media, r is the S-D 
separation, ω is the modulation frequency, and Kx represents constants associated 
with the illumination/detection hardware.  Specifically, these constants depend on 
detector sensitivity and modulation frequency (KAC), source intensity (KDC), and 
phase differences (Kφ) between source and external phase contributions (outside 
noise).  To reduce noise from the environment and since only two slopes are 
required to calculate the optical properties (μa and μs’) at each wavelength, it is 
preferable to use the ac and phase slopes[58].   
The absorption coefficient can be related to chromophore contributions at a 
particular wavelength wherein the total absorbance is a sum of contributing 
absorbers 1 to i[15]: 
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         (7)  
This equation indicates that μa(λ) is dependent on the extinction coefficient (εi) 
of the contributing chromophores multiplied by their concentrations [i].  By 
knowing the μa(λ) at two wavelengths (from the slope acquisitions Eq(1) to Eq(6)) 
and the extinction coefficients for the two chromophores at both wavelengths, the 
two unknown concentrations of absorbers ([Hb] and [HbO2]) can be  
reconstructed.  
Examination of in-vivo measurements of tissue oxygenation found that the 
phase components of spatially resolved spectroscopy at multiple separations 
introduced noise that was confounding to the precise short time changes in 
hemoglobin concentrations necessary for calibration of BF[20].  To retain the 
advantage of FD-NIRS absolute measurements but eliminate this noise, we 
obtained absolute baseline measurements of [Hb], [HbO2], THC, and StO2 using 
the spatially resolved spectroscopy capability during an initial baseline.  These 
absolute baselines were used to calibrate the relative hemoglobin concentrations 
Δ[Hb], Δ[HbO2], and ΔTHC obtained using modified Beer-Lambert calculations 
of single separation (2.5 cm) detected intensities from 690 and 830 nm 
sources[15, 20]. Specifically, the calculation of relative chromophore 
concentrations involves the following procedure:   
First the differential pathlength factor (DPF) or distance traveled by photons in 
a scattering media with a fixed S-D separation must be calculated.  It should be 
noted that the DPF listed here is an empirically determined value which is based 
∑=
i
ia i])[λ(ε)λ(μ
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on the relationship between changes in absorption coefficient, reduced scattering 
coefficient, and S-D separation (r): 
𝐷𝑃𝐹(𝜆) =
�3µs' (λ)�3µa(λ)µs' (λ)∙r
2�3µa(λ)�3µa(λ)µs' (λ)+1∙r
     (8) 
The advantage here of using a spatially resolved FD-NIRS instrument is that 
the baseline μs’ and μa is measured directly for the calculation of DPF. 
Next, “A (λ)” refers to the optical density or the logarithmic change in detected 
intensity due to changes in absorber concentration compared to the initial baseline 
intensity and is calculated by[15]: 
      (9)  
By measuring the optical density (A) at two wavelengths, substituting Eq. 7 for 
the changes in absorption coefficient concentration, and knowing the extinction 
coefficients of the absorbers it is possible to solve for the changes in the two 
chromophore concentrations as shown here: 
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Relative changes in hemoglobin concentration (Eq. 10 and 11) are calibrated to 
absolute units by addition of absolute baseline values of the respective 
chromophore concentrations obtained by the spatially resolved spectroscopy 
method. 
2.2 Diffuse Correlation Spectroscopy (DCS) Flowmetry 
 
DCS measurements of a microvascular flow index are described in detail in 
many previous publications[22, 35] and so will be discussed here more briefly.  
The technology has its roots in the physical modeling of light correlation 
dynamics through turbid media.  By illuminating the tissue with a long coherence, 
CW-NIR source (785, 830, or 854 nm, Crystalaser Inc. NV, USA) a temporally 
varying speckle pattern may be generated at the tissue surface.  This speckle 
fluctuation is detected by a single-mode fiber connected to a single photon 
counting avalanche photodiode (APD, PerkinElmer Inc., Canada).  By using 4 
bundled fibers bundled into a single tip, 4 channels of speckle intensity data can 
be collected simultaneously from a single location.  The data are sent to a 4-
channel autocorrelator board (Correlator.com, NJ, USA), producing normalized 
intensity autocorrelation functions (g2), which are averaged to improve signal-to-
noise ratio (SNR). The intensity autocorrelation function is then related to the 
normalized electric field autocorrelation function (g1) through the Siegart relation: 
g2(r⃑, 𝜏) = 1 + 𝛽|𝑔1(r⃑, 𝜏)|2      (12)  
where g2, again, is the normalized intensity autocorrelation function, g1 is the 
normalized electric field autocorrelation function, τ is the delay time, r⃑ is the 
position vector associated with the photon path, and β is the coherence factor.  β is 
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related to the coherence length, optical system stability, and is inversely 
proportional to the number of speckles observed[15, 20, 30, 33, 59].  The reason 
for introduction of the normalized electric field autocorrelation function g1, is that 
the relation of dynamic scatterer motions (erythrocytes) in turbid media (tissues) 
to correlation diffusion are actually derived in terms of the un-normalized electric 
field autocorrelation function G1.  For a thorough treatment of the derivation and 
solution of the equations that model these processes the reader is encouraged to 
attend the following sources[15, 22, 30].  To abbreviate this more rigorous 
process, it will do here to say that the electric field correlation dynamics, from a 
CW-long coherence source, in a homogenous turbid medium is of the following 
form[15, 22]: 
�𝐷∇2 − 𝑣𝜇𝑎 −
1
3
𝑣𝜇𝑠′𝑘0𝛼〈∆r2(𝜏)〉�G1(r⃑,τ)=− 𝑣𝑆(r⃑)  (13   
Equation 13 is the so-called correlation diffusion equation where α is the ratio 
of dynamic to total (static + dynamic) scatterers, k0 = 2πn/λ is the photon wave 
number (n is refractive index), and 𝑆(r⃑) is the source light distribution term[15, 
30].  Critical to this equation is the term α〈∆r2(τ)〉 (α multiplied by the mean 
squared displacement of dynamic scatterers), which introduces the relation of 
photon correlation decay to the ratio and mean squared displacement of moving 
scatterers.  It should be noted that α and 〈∆r2(τ)〉 are inseparable in this treatment.  
The mean squared displacement of moving scatterers is parameterized by a 
diffusion model via: 
〈∆r2(𝜏)〉 = 6DB(τ)        (14)  
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Of particular importance is the relationship between 〈∆r2(𝜏)〉 and the 
Brownian diffusion coefficient DB given by Eq.14.   Flow through capillary 
networks is tortuous and, in a spatial average, without specific direction, thus 
movement of erythrocytes can be approximated by diffusion.  For more 
discussion of DB and the justifications for its use in biological tissue see 
references[22, 45].  After substitution, a blood flow index αDB can be obtained. 
Equation 14 is supported by experimental fit to diffuse models and Monte Carlo 
simulation[15, 30, 45, 60].  The advantage of this model of autocorrelation 
function diffusion in tissue is that the mathematics of the equation is well defined, 
similar to the photon diffusion equation[15, 30]. For a fixed semi-infinite 
geometry (See Figure 3) alongside a few assumptions, this equation can be solved 
to generate an analytical solution[22, 35]: 
𝐺1(𝜌, 𝜏) =
𝑣𝑆0
4𝜋𝐷
�𝑒
−𝑘(𝜏)r1
r1
− 𝑒
−𝑘(𝜏)r2
r2
�     (15)  
which can then be normalized to the form  
 
          (16)  
where  , , , z0 = 1/(μs’+ μa ) ,           
, Reff  = 1.440n-2  + 0.710n-1 + 0.0636n + 0.668, n = 
1.33 for tissues, and .  The position vectors r1 and 
r2 refer to the S-D geometry with ρ being the S-D separation and values of z being 
related to the boundary condition of light moving through mismatched indices of 
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air and tissue (Reff) at the surface interface of the source ([0, 0, 0]) and detector 
([ρ, 0, 0]).  For a given measurement of g2, and the subsequent calculation of g1, 
the only unknowns in this solution are the optical properties of the medium and 
the flow index αDB [cm2/s].  This unit is not typical of flow and results from the 
spatial averaging of moving scatterers within the tissue volume and the source-
detector geometry[15, 30].   
By assuming or measuring the optical properties of the media (e.g., using 
Imagent), the solution listed in Eq. 15 can be normalized and then employed to 
calculate flow index αDB by least mean square error fitting of the measured g1 
curve with the modeling g1 curve as described by Eq. 16.  The process is 
diagramed in Figure 4.  While each intensity autocorrelation curve only takes a 
few fractions of a second to obtain, many of these correlation curves are averaged 
to reach adequate SNR.  In effect these correlation averaging times are the 
limiting factor for DCS temporal sampling rates. In this study we used ~300 ms to 
produce a single blood flow index.  This index can then be used to calculate 
relative blood flow (rBF) by normalizing αDB(t) to a passive, unperturbed 
baseline via: 
rBF = [αDB(t)/αDB(t = 0)] ×100%     (17)  
This relative measure of blood flow can be calibrated through a well accepted 
protocol combining the measurement of THC increases during a venous occlusion 
protocol as will be discussed in detail in Chapter 2.3[13, 14, 20, 61]. 
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Figure 4. Data Collection and Analysis Regime for DCS 
Detected speckle intensities are collected and autocorrelated to produce intensity autocorrelation 
curves g2.  This data is then related to the electric field autocorrelation function and fitted against a 
model solution to compute the flow index αDB.   Analysis is performed via MATLAB code and 
the fitting between calculated G1 and theoretical solution G1 curves is done by fminsearch function 
for multiparameter least mean squares.  The initial value for αDB is set as 1E-8 and then the values 
of αDB are varied until a minimum error is reached within a certain number of iterations.  This 
method can be used for simultaneous fitting of coherence factor β and αDB since the two 
parameters have no cross talk, as investigated in detail elsewhere[62].   
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2.3 Calibration of Relative Blood Flow (rBF)  
 
 
As has been mentioned earlier, the result of DCS flow index measurements 
requires a calibration to provide an absolute flow value in standard unit 
(ml/100ml/min).  This calibration is provided by the well accepted method of 
performing a venous occlusion (VO) and calculating the arterial inflow via a 
change in blood volume within the compartment[14, 26, 27, 55, 61].  VO is 
accomplished by use of a pressure cuff acting as a tourniquet[13, 14, 61].  
Inflating the cuff to super-diastolic pressures of 50-60 mmHg results in the 
inability of blood to leave the venous compartment.  Strain gauge 
plethysmography, as earlier described, measures gross change in limb volume 
globally.  NIRS however measures the change of THC (proportional to blood 
volume) for a discrete volume of tissue[14, 26, 27, 63, 64].  The equation to 
calculate BF is given as:  
        (18)     
Thus the NIRS measurement during VO provides a rate of change for the 
concentration of hemoglobin in μM/kg/min, which can then be converted to blood 
flow by the application of Eq. 18.  The example measurement of THC using 
Imagent and THC fitting during multiple VOs is illustrated below in Figure 5. 
dt
HCd ]T[
C
1BF ⋅=
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Figure 5. Venous Occlusion Protocol and THC Slope Fitting 
Each occlusion was performed for 10 seconds as the linear increase in THC is transient.  This 
slope was fitted using MATLAB polyfit function for the THC (note that THC and THb are 
interchangeable) between the two marked (vertical line) data points.  The average of these three 
slope values was used to calibrate rBF measurements.  
The conversion to ml blood/100ml/min is performed by dividing concentration 
by  the concentration of hemoglobin in blood (14.1 g/dL) and multiplying by the 
molecular weight of hemoglobin (64.458 g/mol)[17, 31].  You then perform some 
minor unit conversions to take into account the μMol to mol ratio (divide by 106) 
and convert to per minutes (multiply by 60) along with converting from deciliters 
to 100ml and g/kg to resolve the g/kg muscle ratio (multiply by 10,000). Nioka et 
al provides an abbreviated approximation of 1 μM/kg/sec to 3 ml/100ml 
tissue/min[17].  This approximation is very close to Gurley’s calculated value of 
2.74 ml blood/100ml tissue/min per 1 μM/kg/sec [20].   
2.4 Calibration of Relative oxygen Consumption Rate (rV̇O2)  
In addition to flow, oxygen consumption rate is one of the metabolic 
parameters of greatest interest to physiologists and clinicians trying to determine 
the health/level of activity of tissue.  The metabolic activity of a tissue can be 
used to diagnose its functional condition and to discern a pathological loss of said 
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function.  Derivation of oxygen consumption rate requires both the arteriovenous 
difference in O2 concentration and blood flow information of the tissue via the 
Fick principle[31, 45, 65]: 
V̇O2 = BF × ([O2]a - [O2]v)          (19)        
The arterial blood has an assumed constant oxygen saturation (SaO2) of >98%.  
This blood is then understood to deliver some amount of oxygen into the tissue 
and then mixed with the blood occupying the venous compartment.  StO2 may be 
measured by NIRS and from these we can calculate the oxygen extraction fraction 
(OEF) as the arteriovenous difference comparing tissue StO2 during arterial 
occlusion to the initial SaO2:  
OEF = ([O2]a -[O2]v)/[O2]a       (20)  
This equation can then be considered in terms of StO2 saturation, which 
should decrease due to oxygen consumption during arterial occlusion. 
OEF = (SaO2 - StO2)/(γ × SaO2)      (21)  
By approximating > 98% SaO2 as 1 and the term γ (the percentage of blood 
volume contained by the venous compartment) as a constant, we may calculate 
the relative OEF as 
rOEF = (1 - StO2)/(1 - StO2baseline)      (22)  
The relative oxygen consumption rate may then be calculated using only 
optical information obtained by the hybrid optical instrument: 
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rV̇O2 = rBF × rOEF        (23)  
This relative value is useful but the absolute values are desired, as is the case 
for blood flow, in order to compare the potentially meaningful baseline, 
maximum, and minimum values to other measurements obtained using different 
equipment, or to determine physiologically relevant differences between 
patient/subject populations.  
The calibration of absolute V̇O2, similarly to that of BF, is done using a brief 
occlusion of the limb.  In the case of V̇O2 however, it is necessary to increase the 
pressure of occlusion to super-systolic (at least systolic + 50 mmHg) levels for a 
total arterial occlusion (AO).  As a matter of course we prefer to use 225 to 250 
mmHg to ensure halt of blood flow, inasmuch as this is possible.  The DCS rBF 
measurement is useful in this to verify the extent of flow reduction due to AO.  
The rate of change from oxy-hemoglobin to deoxy-hemoglobin should then be 
due to the tissue consumption of oxygen (see Figure 6).  Thus V̇O2 can be 
estimated by fitting the slope of the difference between [HbO2] and [Hb].  The 
calibration of the baseline V̇O2 only requires a single minute of AO, which has 
minimal impact on system hemodynamics (See Figure 6). 
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Figure 6. Arterial Occlusion via HbO2 and Hb Difference Fitting 
At the onset of occlusion, a transient initial increase occurred due to the slow (3-5 seconds) filling 
of the cuff which induced sub arterial occlusion pressures and a very temporary venous occlusion.  
The first minute of desaturation was fitted to determine the rate of change for calibration.  The 
occlusion was continued for another 2 minutes to observe flow/hemoglobin concentration changes 
and the subsequent hyperemic/reperfusion response following the end of occlusion.  These 
parameters can verify the successfulness of the arterial occlusion and reinforce experimental 
confidence in calibration values. 
The change in hemoglobin concentration results in a unit of μM/kg/min and 
may be converted to mlO2/100g tissue/min by knowing the molar ratio of 4 Mol 
O2 to 1 Mol Hb, the molecular weight of oxygen (32 g/mol), the density of O2 
(1.429g/L), and the density of muscle (1.04 kg/L)[18, 31].  As with the calibration 
for flow there exists an approximate conversion factor of 1 μM ([HbO2]–[Hb])/ 
kg/sec which is approximately equal to 0.54 ml O2/100g/min[17]. 
2.5 Gating algorithm, Data Processing and Statistical Analysis  
Data collection during exercise protocols is restricted to only periods of rest 
between contractions by a gating algorithm.   The gating algorithm, described 
more fully in previous publications from this lab, uses analog output from the 
dynamometer foot plate, with signal intensity dependence on footplate position, to 
limit data collection to the time period between contractions[20].  When the foot 
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plate is at rest position the dynamometer analog signal is below a certain 
threshold and data collection is permitted.  When the foot plate is moved through 
the contraction range, the amplitude of the signal passes a threshold (set very 
close to the resting position amplitude) and signals the DCS to halt data 
collection.  Without the DCS sending a TTL signal to the Imagent the FD-NIRS 
remains on standby, following the return of dynamometer output to below 
threshold levels the DCS/ISS data collection cycle resumes.  By default a single 
data point from each device is collected and then the cycle is halted to ensure that 
the next contraction does not induce artifact, thus data collection only resumes 
upon receipt of the return to rest trigger. 
The processing and examination of data often requires the use of filters in 
order to clearly display trends and behaviors.  The only filter employed during the 
extent of this research was a simple convolution (moving average) filter with a 
window size of 10 or 20 data points, depending on the sampling rate.  This filter 
was chosen because it has a much less intrusive effect on data behavior, 
particularly during the rapid onset and end exercise periods of these protocols 
than does a Butterworth or equivalent filter.  The convolution filter manages to 
obtain the central tendency while still retaining the instability of the original data 
set. 
Student t-tests were used to analyze difference in time point means for all 
tables and values in this thesis.  The means used for these statistical analyses are 
from overlaying time series and taking the mean of the entire time series thus 
great importance was placed on the proper timing and synchronization of multiple 
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systems of data collection.  On some occasions, where a precise overlapping of 
data is not possible, the region of interest is selected manually for each period and 
subject, so that the period involved can be precisely controlled/matched between 
subjects.  An example of this is given for the strain gauge data sets which could 
not, due to technical reasons (the two were measured on separate computers 
without TTL links), be aligned exactly with DCS data frames and so venous 
occlusion periods were selected manually for calculation based upon the time 
point where volume began to increase and ended where the linear behavior ended. 
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CHAPTER 3:  BASELINE HEMODYNAMIC ASSESSMENT AND 
STABILIZATION  
Blood flow baseline study protocols were begun by observing baseline 
stability using DCS optical probe on calf muscles in the lower limb (Protocol #1, 
see Chapter 3.1.1).  After a review of literature and previous research in our lab 
narrowed likely effects to be due to contact probes on muscle tissue, whereupon a 
redesign of the optical probe pad (see Chapter 3.1.2) and attachment methodology 
(see Chapter 3.1.3).  Among these factors, local heating could possibly play a role 
for the contact measurements since the probe pad covers the skin and is made up 
of highly insulating materials.  Furthermore, the contact probe is covered by 
layers of surgical tape and compression bandage which also insulate the limb.  If 
a local heating were taking place it would possibly increase skin and muscle 
blood flow[66-68].  Another possible flow modulator would be the application of 
circumferential pressure due to the use of elastic bandage and wrapping tape 
around the limb[56, 69-73].  Such wrapping was desired to secure the optical 
probe due to the use of thick silicon rubber pads and bundled fibers and resulted 
in a somewhat heavy optical probe. Taping and wrapping the probe were the 
default methods of attaching DCS optical probes to tissue in all previous studies.  
A second baseline measurement, from the same subjects and in the same calf 
muscle indicated success in removing the predominant factor related to increased 
blood flow (Protocol #2, see Chapter 3.1.4).   
A confirmation protocol was then performed in the forearm flexor muscles 
(Protocol #3, see Chapter 3.1.5), as the effect had been previously observed in 
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both lower and upper limbs and a body of data existed against which we could 
compare.  This confirmation demonstrated a great increase in measurement 
stability for the redesigned probe and showed that increases in rBF were, most 
likely, due to predominantly local factors.  Lastly the baseline study was 
concluded by performing a repeat of the forearm flexor experiment using a subset 
of those subjects and removing elastic bandaging from the protocol.  Lack of 
increase in the measured rBF for both arms suggested that elastic bandaging is 
most likely to be solely responsible for previous baseline shifts whereas probe pad 
contact is not a factor.  
3.1 DCS Baseline Study Experimental Protocols 
3.1.1 Protocol #1: Gastrocnemius Baseline Stability Evaluation 
Before determining potential flow modulators and their effects it was 
necessary to confirm the baseline shift through an extended in vivo resting 
protocol in the muscle tissue of interest, the gastrocnemius.  Examination of 
resting muscle blood flow shift with DCS had never been done, making this a 
novel measurement.  
For the first experiment, 6 subjects (3 males and 3 females) were recruited and 
their consent obtained via University of Kentucky Institutional Review Board 
(IRB) approved forms.  Subjects were instructed to lie supine and relax for at least 
5 minutes prior to collection of data to allow flow to stabilize.  The DCS optical 
probe was secured to the limb as described in previous publications[15, 16, 28, 
31, 44].  Briefly, the attachment protocol was to disinfect and clean the probe pad 
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and probe site with alcohol prep.  The probe was then placed in contact with the 
subject’s medial gastrocnemius (location determined as the region of greatest 
contraction during a plantar flexion) and lightly held by cotton surgical tape and 
more firmly secured by use of an elastic bandage (ACETm) as illustrated in Figure 
9. In this way external room light was reduced and probe position secured, even
during subject movements.  It was deemed appropriate, as room lights were 
dimmed to assist in preventing signal contamination, to engage subjects during 
the experiment to prevent them from dosing or entering pre sleep states of 
consciousness which can have substantial effects on pulse rate and blood 
pressure[74, 75].  These conversations were of a generally neutral nature to keep 
physio-emotional responses at a minimum whilst holding subject attention.  
Retaining subject consciousness proved to be non trivial as we noted a distinct 
tendency toward sleep due to the combination of low light, and highly static 
supine bed rest for extended periods.   
Baseline measurement duration was set at 40 minutes and the subjects 
instructed to remain as still as possible, since DCS signals and the hemodynamics 
of musculature in general are exquisitely sensitive to motion.  Duration of 
baseline measurement was extended to 40 minutes for two main reasons: first, 
baseline shifts appeared to be a result of prolonged drift that was observed in 
protocols lasting up to 40 minutes (with similar durations planned for future 
studies) and therefore the presence/extent of any shift should be verified under 
similar time courses.  Second, no such extended evaluation of resting muscle 
blood flow had been performed so determining the stability of passive muscle 
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flow was relevant to understanding how meaningful a baseline measurement 
could be in the first place. 
A CW-DCS flow-oximeter system (see Figure 7), detailed in Chapter 1.6, was 
used in this study.  The CW-DCS flow-oximeter makes use of two wavelengths 
(785 and 854 nm) of long coherence laser light for the source and uses 4 bundled 
detector fibers at a single S-D separation of 2.5 cm as illustrated in Figure 7b.  
This relatively large separation used was to ensure that the optical path was 
predominantly inside muscle tissue and to minimize surface layer artifact.  This 
assumption is generally safe as all of our subjects had adipose tissue thicknesses 
(ATT) of less than 8 mm over the gastrocnemius muscles[10, 72, 90].  
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Figure 7. Fiber-Optic Probe and DCS Flow-Oximeter 
The probe pad (a) consists of a simple foam block of dimensions 6×3×1 cm.  The foam is black 
and therefore an excellent isolator of probe signal from room light.  The material is lightweight 
and of intermediate stiffness, resisting curvature around the limb but conforming after application 
of tape.  Probe fibers are held firmly in perpendicular to the skin (not shown).  Multiple holes exist 
for adjustment of S-D separation.  The DCS flow-oximeter (b) employs the 2 source, 4 channel 
detector layout.  Black coating is necessary for fiber optics to reduce external noise.  The 4 
measured autocorrelation curves for each source are averaged to produce a single relative flow 
calculation. 
 The bundled detector fibers allowed for a higher data quality (SNR) compared 
to a single fiber since the flow and oxygenation values can be measured in 
quadrature for a single location simultaneously and averaged.  This eliminated 
some of the random noise and allowed for better quality data even in subjects with 
low intensity signal (highly absorbing tissues).  A sampling rate of 0.5 Hz was 
used with one second of autocorrelation averaging for each source wavelength.  
Flow values at both wavelengths were then averaged.  After this averaging of 
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flow between sources and calculation of relative hemoglobin concentration 
changes from their intensities, a 10-point window convolution filter was applied 
to further reduce high frequency noise and produce a smooth curve that shows the 
central tendency of the raw data.  Only raw data were used for statistical analysis 
however, as filtering/sampling and other such data processing methods can have 
effects on statistical power[76].   
In addition to end point mean comparisons, extended baseline data stability 
was evaluated with linear regression.  It was determined empirically that most 
baseline shifts tended to be pronounced after 20-40 minutes.  Observed short 
duration bidirectional fluctuations (occurring over 2-3 minutes and being 10-20% 
rBF in magnitude) made mean comparisons non-optimal for assessing baseline 
stability.  This is because the peak of a short duration fluctuation at time point 
could be present during the initial 2-minute mean period with the trough of a 
fluctuation occurring during the end time period (or vice versa). This could render 
the time point means statistically different while overall behavior suggested no 
real variation over the long term.  Rather than imposing harsh filters to remove 
these physiological variations, a linear regression model to assess long term 
baseline stability was used.  Typical variation, i.e. standard deviation, of raw data 
ranges between 15% and 30%, meaning at any time point a particular datum could 
be, at worst, between 70% and 130% baseline.  A linear model for stability 
entailed applying a linear fit to the data and evaluating a slope of greater than or 
equal to 0.7 (rBF/min) as a baseline shifted measurement.  For a justification of 
the model and slope threshold of 0.7, see the discussion in Chapter 3.3.1. 
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3.1.2 Optical Probe Design Adjustments 
Following the results of the first in-vivo DCS stability evaluation, we 
determined that some aspect of the measurement was causing rBF to drift upward 
(as shown in Chapter 3.1.1).  This necessitated an investigation into possible 
causes via a search of literature involving limb blood flow modulators.  As 
mentioned in Chapter 1, the two major suspected flow modulators were 
temperature and pressure.  Without the use of precise and somewhat invasive 
probes, temperature and pressure data within the muscle were unavailable to us.  
The lack of suitable measurement equipment for intramuscular/surface pressure 
meant that we lacked a definitive way to measure either parameter, although the 
use of the elastic bandage and tape virtually guaranteed that there were pressures 
being applied to the limb, and that those pressures were probably sufficient to 
affect local blood flow[56, 69-73].  Without hard data on either temperature or 
pressure we decided that the probe/attachment protocol should be designed to 
minimize the contributions from both parameters.  Toward that end, the first line 
of research was to design a probe pad which would be structurally robust as to 
maintain source detector separations, provide a stable platform for optical fiber 
insertion and constancy of optical geometry, and be easily and reliably attached to 
the limb for repeatable measurements with the knowledge that such qualities must 
be evident even during possibly strenuous exercise protocols.  These necessary 
qualities were of foremost importance as these are the conditions for getting 
adequate signals and quality data with the minimization of probe pad area (for 
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less insulation) and adhesive use, not to mention the removal of elastic bandage, 
being crucial to eliminate possible flow perturbation.   
It was determined that, based on several iterations of probe pad design, leaving 
the area between the source and detector uncovered might reduce the temperature 
effects as probe pad/tape insulation were minimized.  By using a three sided 
frame shape it was hoped that the attachment would be of sufficient integrity as to 
be useful during exercise protocols but without the degree of taping/pressure 
application as were present in the original probe (see Figure 8).  Stability of probe 
position and optical fiber geometry was achieved with the use of braided wire 
struts.  This design could maintain source detector separation but the strut, while 
strong in the requisite source to detector axis, was flexible enough to bend 
plastically so that no additional force pulling the fiber tips away from the skin was 
present allowing the probe to match even the relatively severe curvatures of the 
forearm.  
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Figure 8. Redesigned Probe Pad and Attachment to Limb 
 
(a) The fiber-optic probe held in place by the twist wires shown fiber tip length differences can be 
adjusted to fit with spacers made of the same foam as the probe pad.  (b) Probe pad shape allows 
for a single S-D separation fiber arrangement.  A separate probe pad would be necessary for each 
distance as necessary to measure a particular depth.  Wires secure the probe pad and fibers to 
preserve the original orientation throughout the experiment.  Tissue interface side illustrates the 
diffuser, which covers the source fibers as discussed, and the detector fibers held flush to the probe 
surface.  (c) Shows the entire probe as it would be attached during protocols.  The tegaderm film 
has been vented over the open region of the pad to allow heat convection.  Not shown is that the 
fibers would be secured to remove their weight from the tissue surface and reduce amount/strength 
of adhesive used to secure the probe.   
 
An additional challenge arose in the form of isolated incidents of source laser 
burning on the skin, despite the low power emission.  Such burning was 
hypothesized to be due to slight imperfections of the source fibers.  In order to be 
assured that no subjects would be burned, an optical diffuser was constructed 
from Teflon.  This polymer has a very low attenuation of NIR light and so does 
not dramatically weaken the signal intensity of the source light but does broaden 
the spot size of the source.  The diffuser was created by shaving a thin block of 
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Teflon until it was sufficiently thin. This thin (< 0.25 mm, as measured by digital 
caliper) layer of Teflon prevents source fiber/tissue surface interactions without 
significantly attenuating light nor decorrelating the light as the intensity and flow 
signal are not apparently affected.  More information about Teflon diffusers and 
their effects on DCS may be found in the following citation [22].  The probe pad 
now had all the qualities we were looking for in a DCS standalone system.  
Attention now was turned to the problem of how to attach the probe securely 
without applying excessive pressure. 
3.1.3 Optical Probe Attachment Revision 
After some investigation it was decided that a better alternative for surgical 
tape adhesive was Tegaderm thin film dressing (3MTm) which allowed heat to 
escape from the skin, had slightly better tack, and allowed the fiber/probe contact 
to be visually observed during the experiment (refer to Figure 8c).  The Tegaderm 
adhesive proved effective and could be cut to allow a window over the source 
detector area to vent air.  Attachment of the optical probe to the limb by use of a 
4х6 inch piece of Tegaderm thin film with a vent over the middle of the detection 
path allows better convection of trapped heat away from the skin and no elastic 
bandage was employed to minimize pressure application to the muscle tissue. The 
weakness of this set up is that it is more prone to room light contamination and so 
care must be taken to turn off room lights.  Surgical tape may be used in lieu of 
Tegaderm but should not be wrapped around the limb.  Experimentally, a 7 inch 
strip laid along the tibial axis and a 4 inch strip circumferentially proved to be 
sufficient to hold the probe, as detected intensities were stable and no direct 
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source to detector signal contamination could be discerned.  Room lighting was 
turned off for all baseline measurements and did not play constitute an optical 
signal variable for this study but bears consideration for future experiments or 
clinical applications where room lights may be required. 
3.1.4 Protocol #2: In-Vivo DCS Gastrocnemius Baseline Stabilization  
Probe/protocol redesign to remove DCS flow baseline shift was confirmed by 
performing a 40-minute supine baseline test in 6 young healthy controls.  The 
redesigned optical probe (detailed in Chapter 3.1.2) was secured to the medial 
gastrocnemius using surgical tape adhesive (as described in Chapter 3.1.3).  The 
same DCS flow-oximeter system was employed as described in Chapter 3.1.2 
(Figure 8b) but with the probe design employed in Figure 9.  Other than probe pad 
and attachment no changes in procedure or data collection methodology were 
made.  Long term stability of data was evaluated by use of a linear regression and 
slope examination.  The slope threshold of 0.7 (refer to Chapter 3.1.1) serves as a 
rubric for making judgments, in addition to end point mean comparisons, on 
baseline stability.   
3.1.5 Protocol #3: In-Vivo Forearm Baseline Stabilization and Examination 
of Baseline Shift Origin 
 
 
Following gastrocnemius measurements, we performed confirmation tests in 
the forearm flexor muscles, in deference to the familiarity of our lab with 
measuring this muscle group and fairly large subject populations of responses 
against which to compare.  We also attempted to identify the predominant factor 
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causing baseline shifts using a subset of the forearm flexor subjects.  This baseline 
experimental protocol was designed using a concurrent forearm flexor 
measurement protocol in which the right arm rBF was observed using the 
redesigned probe/protocol and the left arm rBF using the original probe/protocol 
(Figure 9).  To ensure that the measurement was truly concurrent we used two 
detector channels per probe with our 4-Channel 2-wavelength DCS flow 
oximeter.  This reduced the number of detector signals averaged, which led to 
lower SNR, but guaranteed synchronicity in data collection and improved 
sampling rates. In addition to the optical probes, a finger plethysmograph 
(Portapres, FMS Inc., Netherlands) was used to observe systemic pulse rate and 
blood pressure to determine global hemodynamic influence on local 
measurements.  
Ten young healthy control subjects were measured in supine for 40 minutes, 
as detailed before.  Probe position was kept consistent between subjects by 
placing the probe over the region of maximum contraction of the forearm flexors 
as determined by having subjects clench their fists.  The entire protocol layout can 
be seen in Figure 10.   
After the completion of the 10 subject measurements, a subset (n = 4) of these 
subjects repeated the measurement (on a different day but under identical 
conditions) with the exception that the original protocol arm (left) did not employ 
elastic bandage.  This was done to examine whether removing the pressure 
component of the original probe would reduce baseline shift, allowing us to judge 
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whether or not probe pad insulation or pressure application was dominant in 
inducing flow alterations (Figure 10).   
 
 
Figure 9. Original Optical Probe Position and Attachment 
Attachment was performed as depicted with tape to initially hold the probe (left), elastic bandage 
to secure this position, and surgical tape to maintain elastic bandage pressure (right).  The location 
was based upon the maximum contraction response for clenched hands/flexed wrists.  For 
gastrocnemius measurements the probe was positioned based upon the greatest contraction during 
plantar flexion in the medial gastrocnemius. 
 
Figure 10. Concurrent Baseline Protocol Set-up 
Subjects are positioned on a bed with head and forearms comfortably resting on padding/pillows.  
Forearms are slightly elevated to reduce venous pooling associated with extended stationary 
positions.  Placing the hand at heart level also is required for accurate finger plethysmography 
pressure and pulse rate data.  Room lights are turned off and the subject is asked to remain at 
resting supine for 5 minutes prior to start of data collection. 1) refers to the original probe and 
attachment protocol on the left arm, 2) refers to the newly designed probe/protocol employed on 
the right arm, and 3) indicates the finger plethysmography instrument. 
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3.2 DCS Baseline Study Results 
3.2.1 Protocol #1: In-vivo DCS Baseline Gastrocnemius Stability Evaluation 
 
Relative blood flow significantly (p < 0.05) increased throughout the protocol 
(refer to Chapter 3.1.1 for protocol details) from the first two minutes of baseline 
to the final two minutes of the experiment for all but one subject (see Table 1).  
The group mean of the final 2-minute value was 163.5 ± 5.9%, which 
represented a tendency towards flow increase (see Table 1, Figure 11).  The 
significance of difference was determined via Student t-tests for the two groups 
(initial 2 minutes of data vs. final 2 minutes).  Subject 6 data was discarded as the 
detected light intensity was only 10-15 KHz and the resulting calculated relative 
flow, while in rough agreement with other subjects’ trends, was laden with noise 
(standard deviations of greater than 90%).  Only one subject (Subject 1) had a 
trend uncharacteristic of the others.  The change for this subject was also 
significant but somewhat anomalous in that the trend was for decrease.  The net 
result is that the group mean response is higher than baseline after 40-minute 
supine bed rest. 
Table 1. Baseline Measurement Means and Fitting Slope 
Significance between data sets is denoted with an *.   
Subject Initial mean rBF  
(2 minutes) 
Final mean rBF  
(2 minutes) 
Linear Fit Slope 
1 100.0±23.6 87.9±52.6 -0.21 
2 108.0±22.8 208.2±32.7* 3.41 
3 105.1±9.4 217.8±15.4* 4.56 
4 102.0±22.3 168.9±27.5* 2.39 
5 99.6±6.0 122.8±14.1* 0.62 
6 N/A N/A N/A 
Group Mean 102.9±3.9 161.1±5.9* 1.39 
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A linear fit of time series data showed a baseline shift that was in a distinctly 
positive direction (Figure 11). While responses varied substantially between 
subjects the increasing trend is consistent.  For subjects with obvious elevations in 
baseline, the statistical mean tests are sufficient to describe data, however, given 
the somewhat large standard deviations associated with individual subjects for 
particular time points, as discussed in Chapter 3.1.1, data stability in non-obvious 
cases would be difficult to evaluate without resorting to unrealistically large 
averaging times (5-10 minutes) and would still be greatly influenced by outliers 
while linear models would be more insulated against such disturbances.   
 
Figure 11. Group Mean (n = 5) Relative Flow with Linear Fit 
Filtered mean data (green dots) demonstrate the central tendency of the data via a 10 point 
convolution filter while standard error (red bars) demonstrates difference between subjects and 
clearly shows an increase in flow during the baseline. 
 
End value data for the old probe were significantly (p < 0.05) greater than 
baseline, and were increasing at a substantially greater (slope = 1.46) rate than the 
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0.7 model threshold for sustained elevation (Figure 11).  For more explanation of 
the linear fit slope threshold see the discussion in Chapter 3.3.1. 
3.2.2  Protocol: #2: In-Vivo DCS Gastrocnemius Baseline Stabilization 
The typical flow response for these same 6 subjects (see Chapter 3.2.1) 
oscillated around the baseline value (Figure 12) throughout the protocol with the 
revised probe (See Chapter 3.1.4) but some subjects exhibited a marked decrease 
(15-20%) in flow (Figure 13).   
 
Figure 12. Typical Subject Response with Redesigned Probe: 
Stable Blood Flow 
The most typical response to baseline protocol with the revised probe is a general stability around 
100% with a minimal difference between end and beginning relative blood flow.  The blood flow 
naturally fluctuates around this baseline value highlighting the variable nature of microvascular 
flow.  A linear fit of the data shows an intercept close to 100% supporting the stability of the data 
and the slope = 0.112 is much less than the empirical 0.7 threshold for a shift.   
The decreases in flow (Figure 13) observed are likely attributed to the effect of 
prolonged bed rest, for a justification of this decrease see Chapter 3.3.3.  Systemic 
indicators such as pulse and mean arterial pressure were considered to be 
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important to facilitate a better understanding of these trends and were measured in 
later studies.   
 
Figure 13. Typical Subject Response with Redesigned Probe: 
Decreased Blood Flow 
The second typical response is that of a slight decrease (20%) from baseline.  The linear fit of data 
has a positive slope but has a substantially lower intercept which is indicative of the stability of the 
latter part of the data following an initial 10 minutes period of decrease.   This highlights the 
weakness of using a linear model to describe nonlinear systems and would also indicate that the 
some subjects can experience a slightly stressed state for longer than 10 minutes even at rest and 
following at least 5 minutes of supine experimental set up. 
Group mean response was an oscillatory and slightly decreasing time course 
with end mean values comparable to the initial baseline value (Figure 14).  
Despite the degree of variation of blood flow in time for each subject, the mean of 
each subject showed remarkable stability which supports our hypothesis that the 
removal of insulation and pressure application from probe design stabilizes the 
system (Figure 14).   
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Figure 14. Group Mean Comparison of Original (n = 5) and 
Redesign (n = 6) Gastrocnemius Baselines 
The redesigned probe (bottom) has a final mean value (final 3 minutes) of 93.3% of baseline 
compared to the initial (3 minutes again) value of 102.5 and a linear fit slope of -0.356 which is 
less than the 0.7 value attributed to describe a baseline shift.  This is compared to the initial (3 
min) mean of 102.9 and final (3 min) mean of 163.5 for the previous probe (top) and its obvious 
shift of 1.46, which is double the empirical threshold of 0.7.    
Statistical analysis of these data sets showed that the initial values of the 
group means for either probe (first 2 minutes) was not significantly different 
meaning that both studies had a stable initial relative blood flow and that the 
difference between end values would then reflect the long term effects of the 
probes/protocol on relative blood flow.  The same analysis, applied to the final 2 
minutes of each group mean time course, showed significant difference between 
the two with the redesigned probe having a value significantly (p < 0.05) lower 
than both the initial 2 minutes of the measurement and the final 2 minutes of the 
original probe baseline.  The redesigned probe data stability (as assessed by linear 
fit), is much increased compared to the previous probe design with a reduced 
slope and magnitude of difference in end points.  
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These results support the hypothesis that the baseline shift was induced by our 
measurement protocol and that the redesign (see Chapter 3.1.2 and 3.1.3) of said 
protocol was successful in reducing the effect.   
Table 2 summarizes the individual and group mean initial and final 2-minute 
time period means as well as which ones are significant and the linear fit slope of 
each. 
Table 2. Probe Redesign Summary for Gastrocnemius Baseline 
Subject Revised Probe 
Initial mean rBF  
(2 minutes) 
Revised Probe   
Final mean rBF   
(2 minutes) 
Linear Fit Slope 
1 102.3±6.5 101.7±5.5 0.11 
2 103.5±7.5 101.5±8.1 -0.17 
3 106.1±12.8 65.7±15.0* -0.55 
4 104.2±22.6 102.8±16.4 0.13 
5 97.8±14.3 85.6±13.3* -0.39 
6 100.9±7.1 102.8±10.6 0.20 
Group 
Mean 
102.5±2.5 93.3±1.7* -0.36 
The smaller changes in baseline over the 40 minute duration and the linear fit slope of values 
(magnitude as well as direction) demonstrate a marked improvement of measurement stability in 
vivo for the redesigned protocol.  Standard deviations are less than those of the previous probe 
which suggests an improvement in the S/N ratio for these data sets.   
3.2.3 Protocol #3: In-Vivo DCS Forearm Baseline Stabilization and 
Examination of Baseline Shift Origin 
 
 
The use of relatively larger subject population (n = 10) and concurrent 
measurements enabled us to determine a significant difference (p < 0.05) between 
local hemodynamics in both limbs during the 40-minute baseline protocol in 
forearms (see Chapter 3.1.5).  All subjects had significant changes in blood flow 
compared to the baseline but only 3 had that change in the increasing direction.  
53 
 
The remainder exhibited a decrease in final 2-minute rBF that ranged from 10 to 
40%.   
Figure 15. Typical Subject Contra-Lateral Relative Flow   
Most subjects showed a significant decrease in rBF with a linear fit far below the 0.7 threshold for 
the right arm with redesigned probe (top panel). This is compared to the obviously increasing flow 
(mean 200%) in left arm with original probe (bottom panel), and a linear fit triple that of the 
threshold (mean slope: 2.26).   
 
Figure 16. Atypical Subject Contra-Lateral Relative Flow 
Of the three subjects this one had the most extreme increased blood flow with values approaching 
those expected during exercise.  The left arm blood flow (original probe) increases to 370% of 
baseline while the redesigned probe has a still significant 163% increase.  Such dramatic increases 
may be due to the involvement of systemic parameters. 
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The two distinct response trends are best shown in Figures 15 and 16, the 
atypical response (Figure 16) is characterized by a very large increase in blood 
flow over the duration of measurement, increasing to 370% of the initial value in 
the previous protocol arm and 160% in the redesigned probe arm.  The expected 
response (Figure 15) showed an increase in the old probe arm from 100 to 200% 
of baseline and a decrease in the new probe arm of 100 to 75% of baseline.  
Trends of increase in previous probe arm rBF and a much reduced increase in 
redesigned probe arm, with the same systemic cardiovascular environment, 
indicate that the baseline shift had been dramatically reduced and was caused by 
local factors.  Linear fits for each subject are characteristic for baseline shifts in 
all previous probe arms but not for new probe arms, except for those atypical 
response subjects (Table 3).  
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Table 3. Summary of Relative Flow Data Baseline Means for 
Contra-Lateral Forearm Measurement 
Subject Previous Probe 
Initial mean rBF 
(2 minutes) 
Previous Probe 
Final mean rBF 
(2 minutes) 
Linear Fit Slope 
1 96.8±24.6 142.1±27.8* 1.18 
2 105.1±16.7 232.2±17.8* 3.09 
3 108.1±14.7 145.5±23.4* 1.06 
4 95.5±42.3 124.2±15.4* 0.72 
5 106.0±13.1 149.5±34.2* 1.10 
6 102.2±30.9 224.4±21.6* 3.12 
7 95.4±15.1 134.3±13.1* 1.04 
8 100.1±11.1 195.4±25.5* 2.28 
9 97.0±13.1 174.3±20.7* 2.16 
10 111.2±16.4 367.3±29.6* 6.37 
Group 
Mean 
101.7±1.8 193.6±5.6* 2.26 
Subject Revised Probe 
Initial mean rBF 
(2 minutes) 
Revised Probe   
Final mean rBF  
(2 minutes) 
Linear Fit Slope 
1 98.6±15.7 94.2±22.6 -0.30 
2 102.9±25.9 89.2±34.9 0.16 
3 102.9±8.0 92.6±14.1* -0.03 
4 100.2±24.2 80.2±19.1* -0.84 
5 101.2±11.6 89.3±12.5 -0.36 
6 110.4±18.3 184.0±21.2* 1.11 
7 98.4±12.9 69.2±10.9* -1.13 
8 99.0±16.2 60.8±11.1* -0.99 
9 105.6±22.2 228.3±46.7* 3.37 
10 106.9±22.8 163.8±31.6* 1.32 
Group 
Mean 
102.1±1.8 119.1±3.4* 0.28 
Significant change in baseline flow (p < 0.05) is noted for all subjects and group means and this 
difference applies both to final 2 minutes vs. initial 2 minutes and to difference between final 
2minutes for each probe.  Note the larger standard deviations for these data as only two detectors 
were averaged, which supports the use of a multiple detector bundle fiber device for better data 
quality.  
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Figure 17. Group Mean (n = 10) Contra-Lateral rBF with Linear 
Fitting and Standard Error 
The original probe design shows a steadily increasing trend that is consistent with gastrocnemius 
baseline measurements but generally higher (slope = 2.24 in arm compared to slope = 1.39 in leg) 
with an overall increase of 199.1% (arm) compared to 163% in leg.  The redesigned probe shows a 
behavior consistent with leg measurements. Redesign (small linear fit) but has a still significant 
increase due mostly to a short onset increase.  This increase is almost certainly due to the large, 
rapid increase observed in the 3 anomalous subjects, as depicted in Figure 17, which would have 
skewed the mean upwards initially but was offset by general trends of decrease for later time 
periods.  Even so, the end result is a minor (117.9%) elevation over 40 minutes and a linear fit 
which suggests stable baseline. 
 
Group mean time series show greatly reduced baseline drift in redesigned arm 
with a linear fit of 0.29 and final value of 119% of baseline while relative flow in 
the previous probe site rises dramatically to a mean 193% of baseline and has a 
mean linear fit of 2.24 (Figure 17).  Statistically the two arms had a non 
significant difference in initial 2 minutes of baseline flow (p > 0.05) and a 
significant difference in final baseline flow both between probes and initial 2 
minutes values for each probe.   
Systemic data trends show that subject systemic parameters may have played 
a role in anomalous flow responses as both MAP and pulse rate increased for the 
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subjects experiencing greatest contra-lateral flow increase (Table 3 and 4, Figure 
17 and 19).    
Table 4. Forearm Study Summary of Systemic Parameter Means 
Subject Subject Initial 2 
mins MAP 
(mmHg) 
Subject Final 2 
mins MAP 
(mmHg) 
Subject Initial 2 
mins Pulse Rate 
Subject Final 2 
mins Pulse Rate 
1 64.0±4.7 64.8±4.7* 60.5±10.0 54.9±2.0* 
2 73.0±4.2 88.0±5.2* 77.2±6.2 62.5±4.9* 
3 99.2±6.5        ~103 82.9±5.1                   84.0±3.9 
4        ~62 63.0±3.6 82.8±3.9 72.2±6.1* 
5 69.5±3.3 81.5±2.0* 60.4±4.1 58.5±4.1 
6 69.3±9.1 76.1±6.3* 71.2±9.8 61.7±5.2* 
7 59.0±2.9 73.3±4.1* 64.6±5.2 60.5±3.1* 
8 76.0±2.9 88.0±2.2* 59.0±2.8 56.4±2.7 
9 84.9±9.0 107.9±6.3* 71.6±6.7 70.8±7.1 
10 65.3±3.4 87.5±5.7* 65.3±7.4 75.2±4.6* 
Group 
Mean 
73.3±0.7 82.1±0.6* 69.7±0.8 65.7±0.5* 
Significant difference from initial baseline (denoted *) to end baseline is found in most subjects 
but MAP and pulse rate often differ in direction.  Pulse rate decreases, as expected in resting 
subjects, and MAP increases although it is not well understood why.  Some literature indicates that 
compression of the limbs can induce reflexive MAP increase[77]. ~ indicate finger 
plethysmograph recording errors which produced gaps in data collection for these regions, the 
mean was taken from available data within this time period. 
Group MAP response shows an increase from 73.3 to 82.1 mmHg while pulse 
rate decreases from 69.7 to 65.7 BPM.  Group mean values for both MAP and 
pulse rate have significant changes in final vs. initial two minute mean values 
with MAP increasing and pulse rate decreasing.  These changes are consistent 
with a body of literature that indicates increased vagal tone during supine postures 
can produce increased blood pressure and decreased pulse rate[78-80].   
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Figure 18. Group Mean (n = 10) Time Series for Systemic 
Parameters 
Despite a high degree of variation within each time series the overall behavior of systemic group 
means is somewhat stable with a slight but significant (p < 0.05) decrease in pulse rate and a 
similar magnitude significant increase in MAP. 
Results from 4 subjects, elastic-free, sub groups show similarly stable blood 
flow response with an absence of linear fits that meet the standard of baseline 
shift occurrence (Table 5, Figure 19).  Initial two minutes of baseline rBF held at 
102.1% and 101.2% for both arms (the former being original probe, the latter 
being the redesigned probe) and both demonstrated a significant (p < 0.05) 
decrease to 89.7% and 93.8% of baseline respectively.  Mean linear fits of rBF are 
likewise indicative of stability with slope values of -0.32 and -0.29 for previous 
and redesigned probe (Table 5).  Changes in systemic parameters indicate that 
overall pulse rate is decreasing during the protocol while MAP increases.  These 
effects seem consistent with previous 10 subject forearm observations and 
produce a non-increasing, more stable rBF (Tables 4 and 6, Figures 17-19).   
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Table 5. Summary of 4-Subject Sub-Group Relative Flow without 
Compression Bandage 
Subject Original Probe 
Initial  mean 
rBF (2 minutes) 
Original Probe 
Final mean rBF 
(2 minutes) 
Linear Fit Slope 
1 105.8±14.9 124.5±24.5* 0.53 
2 103.8±28.9 68.8±14.8* -0.98 
3 97.6±11.9 78.6±14.9* -0.57 
4 98.7±10.3 87.0±7.6* -0.31 
Group Mean 101.5±4.6 89.7±5.4* -0.32 
Subject Redesigned 
Probe Initial  
mean rBF 
(2minutes) 
Redesigned 
Probe Final 
mean rBF 
(2minutes) 
Linear Fit Slope 
1 98.9±31.8 104.6±50.5 -0.30 
2 106.2±38.1 107.2±23.6 0.14 
3 95.1±11.3 73.4±10.2* -0.10 
4 103.5±13.9 89.9±15.8* -0.65 
Group Mean 100.9±5.7 93.8±7.5* -0.29 
 
No subject had initial 2 minutes flow significantly different (p > 0.05) than 100%.  Most but not 
all had significantly (p < 0.05) lower final 2 minute rBF and multiple mean comparison.  All linear 
fits had slope < 0.7 and this applied to magnitude as for all but one subject.   
 
Table 6. Sub-Group Systemic Parameter Mean Summary 
Subject Subject Initial  
2 mins MAP 
(mmHg) 
Subject Final  
2 mins MAP 
(mmHg) 
Subject Initial  
2 mins Pulse 
Rate 
Subject Final  
2 mins Pulse 
Rate 
1 83.1±9.5 78.7±5.6* 78.6±8.4 62.1±10.0* 
2 58.6±3.3 76.8±2.5* 64.5±4.5 71.9±5.7* 
3 89.1±4.7 113.5±5.3* 67.0±8.2 71.1±8.7* 
4 89.7±5.6 80.7±5.5* 58.9±4.7 55.6±5.3* 
Group Mean 80.2±1.3 87.4±1.4* 67.3±1.4 65.2±2.3* 
Responses vary highly in both magnitude and direction.  This inconsistency indicates that there is 
no dominant probe related effect on either pulse rate or MAP.  All changes from baseline are 
significant (p < 0.05) but this is not very informative given the sample size.   
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These two forearm muscle hemodynamic measurements show distinctly 
different trends of response (Figures 17 and 19) with the most obvious effect 
being seen on local rBF endpoints (Table 3 and 5).  The changes in 
cardiovasculature during the measurement were consistent with those of the 10 
subject trial with a slight increase of MAP being observed and this increase in 
pressure may be attributed to the supine posture rather than compressive vascular 
reflex, given the absence of the elastic bandage[77-80].  Pulse rate appears to be 
largely slowed during baseline study (given the significant decrease for most 
subjects and group means) which is supportive of the assumption that all subjects 
were measured at rest.      
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Figure 19. Sub-Group Mean (n = 4) Contra-Lateral rBF with 
Linear Fitting and Baseline Systemic Parameters 
With the removal of the elastic wrap both probes had significant (p < 0.05) decrease in final 2 
minutes rBF compared to initial 2 minutes but neither baseline or end final rBF was significantly 
(p > 0.05) different from each other.  The linear fit of both time series showed a tendency to 
decrease and the magnitude of the shift was much less than our threshold of 0.7.  Pulse rate is for 
the most part stable around its initial value without trend in any direction.  MAP shows markedly 
more change in response but overall the extent of this increase remains fairly small (though 
statistically significant).  Greatly indicative of predominant elastic bandage effect on local 
microvascular blood flow.  Systemic parameters appear to be more independent of compressive 
effects.   
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3.3 DCS Baseline Study Discussion  
3.3.1 Protocol #1: In-vivo DCS Gastrocnemius Baseline Stability Evaluation 
Initial in-vivo contact probe data clearly showed that some aspect of the 
measurement was inducing a slow hemodynamic response in the limb (see Table 
1).  Relative changes in hemoglobin were of no consequence with few consistent 
trends, as would be expected in a resting baseline measurement.  Subjects 
possessed a slight increase in total hemoglobin (not shown) but, again, this change 
was subtle and consistent with the more interesting changes in relative blood 
flow.  The absence of global systematic measurements (blood pressure and pulse 
rate) in this protocol meant that baseline status had to be assumed and 5 minutes 
bed rest prior to the beginning of the protocol was deemed sufficient but 
confirmation via a finger plethysmograph was desired to confirm systemic status.   
Linear fits were performed to characterize the global data trends for a more 
useful examination of rBF changes over time.  An empirically set threshold of 
slope ≥ 0.7 was chosen to linearly model a significant baseline shift.  Such a 
threshold, not based on physiological theory and predicated solely on examination 
of data, is justified as during our initial 40-minute baseline study it was found that 
end point rBF data standard deviations (calculated for each subject from Table 1, 
Chapter 3.2.1) averaged 28.4%.  Against a theoretical final mean of 100% (ideally 
stable), the z score for our measured final mean (161.1%) was 2.15 meaning that 
it was more than 2σ or possessed a less than 5% rate of occurring due to chance.  
A 1σ threshold for increase over 40-minutes indicates that an observed mean 
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increase could occur up to 128.4% approximately 1 in 3 times.  A linear fit slope 
≤ 0.7 would have the effect that an increase in rBF (128% over 40 minutes with 
intercept = 100%) would fall within a single standard deviation of the expected 
100% final stable baseline mean, but larger slopes would not.  That is to say, 
starting at 100% theoretically stable rBF, the increase due to variance (within a 
single standard deviation) over a period of 40 minutes can be up to 128%, given a 
0.7%/min slope.  Stated as an equation, stability was determined thusly: 128% = 
m %/min ∙ 40 minutes + 100%; m = 0.7 (%/min) 
Thus a linear fit of less than this would show that the overall tendency for 
change is small (less than a standard deviation) and well within reason given our 
data variation, a larger fit shows a drift that is larger than variance would predict, 
and increasingly unlikely to be due to chance.   Such an evaluation also minimizes 
the influence of short duration (2-3 minutes), low magnitude (10-20%), 
fluctuations as well as of high frequency noise observed on end point mean 
comparison Intercepts of the linear fit were not considered important, as long as 
they remained close enough (within 15%) to the initial baseline value of 100% 
that this value could be assumed to be the stable end baseline value.  Sudden 
initial or final changes could potentially deviate intercepts sufficiently as to make 
the simple linear model of stability/shift inaccurate but it was determined to be 
sound enough to make a viable determination of baseline data behavior and was 
used for all baseline analysis.   
Short duration rBF fluctuations are hypothesized to be related to many 
possible factors. e.g., subtle motion artifacts, postural contractions of nearby 
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muscle groups, changes in breathing pattern, pulse rate, arterio-venous tone, blood 
pressure, etc. that are difficult to accurately observe/monitor.  Concurrent 
monitoring with EMG may be useful to distinguish the local muscle activity and 
assess the degree to which small muscle motions may affect blood flow but was 
unavailable to our lab for this study.   
3.3.2 Protocol #2: In-Vivo DCS Gastrocnemius Baseline Stabilization 
The measurement philosophy for this optical research is to avoid invasive 
methods to make hemodynamic or intramuscular condition measurements.  Such 
noninvasive oriented research is optimal for developing methods directly 
applicable to the clinical environment given that all invasive procedures carry an 
increased risk of infection.  This does mean that we must assume intramuscular 
conditions (relying upon literature for these assumptions), if they cannot be 
observed without the use of invasive procedures.  This means that the 
methodology employed to mitigate possible contact probe effects was to reduce 
overall probe area, while retaining previously mentioned structural elements and 
signal stability, and reduce the amount of circumferential pressure applied to the 
limb, in an attempt to avoid intramuscular pressure increases and temperature 
elevation without being able to measure either parameter.   
Several iterations of probe design were attempted and tested before the final 
design was adopted.  Attachment protocol iterations found that acrylic liquid 
adhesives and similar substances were non optimal since most adhesives strong 
enough to maintain stable probe position proved difficult and uncomfortable to 
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remove as well as having some risk of skin irritation.  In the end, the reduction of 
probe pad weight and securing of fibers allowed the use of the thin film adhesive 
Tegaderm which effectively reduced circumferential pressure application and 
insulation of the measurement region.  While not optimized for multiple 
separations or adaptation of Imagent probe, the probe/protocol redesign 
successfully reduced the degree of probe influence on resting baseline blood flow 
over long duration measurements (see results in 3.2.2).  Responses varied between 
relative stability and slight, but significant, decrease in end-point mean 
comparisons.  All measurements, as well as the linear regression model of those 
measurements, showed a recovery of stable baseline measurements (see Table 2).  
The effectiveness of the linear regression model designed for assessing baseline 
stability was demonstrated to be effective at determining between overall stable 
and drifting blood flow trends for this study.  This protocol was successful in 
reducing baseline shifts by use of the redesigned probe and new installation, but 
did not contain a means for identifying the dominant flow modulator responsible 
for this behavior.  As such, another protocol was necessary to isolate the dominant 
variable influencing microvascular tissue hemodynamics.  The next study 
(Protocol #3) used a relatively larger sample size to add statistical power, 
measured the forearm flexor muscles to confirm the phenomenon and its 
remediation in a separate and previously affected muscle group, and differentially 
measured attachment protocols and probe pad differences between limbs in a 
subset of the sample population. 
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3.3.3 Protocol #3: In-Vivo DCS Forearm Baseline Stabilization and 
Examination of Baseline Shift Origin 
 
 
At rest, in the supine position, there is a tendency for blood pressure (systolic 
and therefore MAP) to rise and pulse rate to decrease[78-80].  Resting muscle is 
absent working muscle related metabolic/mechanical vasodilatory signaling. 
Given the lack of parasympathetic innervations of the muscular microvasculature, 
the aforementioned MAP increases and myogenic response of feed arteries 
produce an overall higher vascular resistance[81].    The decreased perfusion 
pressure of the lower limbs in supine, coupled with increase in vascular resistance 
and lack of vasodilatory stimulation, is seemingly able to produce a decrease in 
muscular perfusion, thus the decreased muscle blood flow (rBF) trend during 
these extended baseline measurements.  This result is independent of the optical 
probe set up and is a consequence of systemic/local hemodynamic response to 
supine posture.  Since no literature has been found which reports continuous, 
extended, resting baseline microvascular flow, this data, while in agreement with 
basic physiological principles, may be somewhat novel. 
Removal of the elastic bandage removed subsequent baseline shift from the 4 
subject subgroup regardless of which probe pad was used (see Table 5).  This 
lends support to the hypothesis that application of circumferential pressure on the 
tissue to hold the probe pad in place is the predominant hemodynamic modulator 
inducing a significant elevation in subject local relative blood flow.  The increase 
of MAP and blood flow in most subjects using the previous probe/protocol can be 
majorly attributed to the compression bandage having a local and systemic effects 
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which is linked to mechanically induced arterial vasodilation and autonomic 
response[70, 71, 77-79, 82].  The decreases in rBF observed (both in 
gastrocnemius and forearm flexors) during baseline measurements with revised 
probe and protocol are likely a result of the prolonged supine posture[78-80]. 
Group mean data for the forearm studies (Protocol #3) agree with the findings 
from previous gastrocnemius study (Protocols # 1 and 2) confirming that the 
original probe design induces a baseline shift while the redesigned probe/protocol 
does not.   
Linear regression models successfully differentiate between short duration 
increases and true tendencies to increase over the duration of the measurement.  
The redesigned probe/protocol while significantly different from baseline (p < 
0.05) at 102.1% to 119.1% only had a mean linear slope of 0.28, due to a sudden 
initial increase in rBF that is subsequently stable.  This mean behavior is 
attributable to the effects of 3 atypically increasing subject responses offsetting 
with the more normal decreasing response in the long term, resulting in an initial 
increase followed by stability.  These atypical responses are discussed further 
below.   
There were found to be 3 subjects whose rBF increased in both arms 
regardless of probe/protocol and each of these was associated with the largest 
increases in rBF for the previous probe design (see Table 3).  While unexpected, 
the data was accepted as reliable and a result of local/systemic hemodynamic 
factors rather than some outside source of noise.  This stance is adopted as the 
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intensity and signal contact data were of good quality and no systematic or 
protocol deviations were noted in any of these subjects.     
Atypical subject responses are included in the group mean which helps to 
explain the observed behavior therein.  Most subjects had a final 2 minutes MAP 
value either non-significantly or 5-10 mmHg higher than initial 2 minute means.  
Subjects 9 and 10 exhibited drastic flow increases in both limbs and MAP 
increases of 23.0 mmHg and 22.2 mmHg respectively which would amount to a 
large increase in perfusion pressure at the microvascular level and at least 
suggests a non-stable baseline global hemodynamic environment.  Reasons for the 
atypical increases could be attributable to some systemic upregulation (see the 
MAP increases for those subjects) or local activity but are not certainly known. 
Future studies must be cautious in applying protocols with attention to detail to 
prevent unknown variables from inducing potentially large changes in the 
sensitive microvascular hemodynamics.   
In summary, despite the anomalous data, the general trend for the 10 subject 
group is in agreement with the previous gastrocnemius study (Chapter 3.2.1 and 
Chapter 3.2.2) in that previous probe/protocol application induced significant 
increases in resting baseline rBF while the redesigned probe/protocol greatly 
stabilized the measurement over the duration of the protocol.  By concurrently 
measuring forearms with different optical probes, this study gives us reason to 
believe that local hemodynamic parameters are predominantly at the heart of the 
baseline shift and are likely related to vascular tone changes in the underlying 
muscle at the probe site[66-70].  This stance is further supported by highly 
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divergent local responses given the same global increases in MAP and decreases 
in pulse rate, expected of prolonged supine bed rest (see Table 4). 
3.4 DCS Baseline Study Conclusions 
 
 
Following the completion of analysis on both leg and forearm studies, it can 
be ascertained that the original contact probe and attachment protocol were 
inducing a significant flow perturbation, likely by way of inducing local 
vasodilation via elastic bandaging[16, 31, 69, 72, 73, 77].  Without being able to 
measure the intramuscular conditions regarding heat and pressure we attempted to 
design around evaluation of both parameters and obtained a final design that was 
efficient in terms of probe weight, easy to use, possessed of rigidity, durability, 
and fiber optic support.  This redesign subsequently appeared to stabilize in vivo 
measurements.  Study in both the gastrocnemius and forearm found the newly 
designed probe/protocol reduced the contact measurement hemodynamic effects 
which was significant with regards to local blood flow shift. An additional 
advantage to the major findings is that the probe pad was not the dominant factor 
in measurement induced hemodynamic shifts and we can therefore apply the 
hybrid DCS/Imagent probe (Illustrated in Figure 20) to measure absolute 
quantities for both flow and oxygen consumption rate, following the appropriate 
calibration protocols[31, 32].    
Having satisfied our 3 major aims for this blood flow baseline shift study, i.e., 
verifying the presence of a gradual increase in rBF in healthy controls, stabilizing 
the measurement through probe redesign and protocol adjustments, and 
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ascertaining the origin of the baseline shift, we were now able to make continuous 
measurements in vivo with confidence that the measurement procedure itself was 
as minimally intrusive to the observation as possible. 
  
71 
 
CHAPTER 4:  TRANSLATION OF ABSOLUTE 
HEMODYNAMIC/METABOLIC MEASUREMENT METHODS TO THE 
GASTROCNEMIUS DURING DYNAMIC EXERCISE  
 
Our lab had previously investigated hemodynamics of the lower limbs using 
DCS/NIRS oximetry and validated this data against other technologies[16, 28].  
However, these methods involved previously described optical probe attachment 
which was demonstrated to induce instabilities in rBF which we believe to have 
been addressed using current methods.  In addition to this, our recent use of 
calibration techniques and dynamometer controlled exercise protocols[31, 53] had 
not been tailored to the lower limb, nor had we developed a protocol for exercise 
that would be easily comparable to literature.  This research then focused on 
addressing these by developing an exercise and calibration protocol for use in the 
lower limb that would be comparable in duration/intensity to those of literature 
and, optimally, can be done by both healthy controls and PAD patients [13, 18, 
19, 31, 54, 83, 84]. The success (or failure) to produce consistent and comparable 
responses would determine if these techniques were sound and would offer a 
platform to extend measurement to patient populations. 
 
4.1 Gastrocnemius Translation Experimental Protocols 
 
 
The primary motivation for using such an exercise protocol was in developing 
a protocol that could examine working muscle tissue hemodynamics and also be 
used to compare between healthy controls and PAD patients. By applying our 
recently developed calibration and measurement methods to the lower limb, this 
study would provide us a set of hemodynamic responses in young healthy 
72 
 
controls, using a protocol adapted to our equipment, as was the case in previous 
forearm studies[20].  The successful transference of our calibration and 
measurement techniques in the lower limb would then be our basis for 
comparison in future studies, perhaps in healthy control populations age-matched 
to standard PAD populations.    
Secondary to the above motivation was the desire to cross-validate our resting 
baseline BF measurements using strain gauge plethysmography (SGVP) during 
our previously described microvascular flow calibration measurements.  Such 
investigation marks a unique aspect of this study, as we had not previously 
concurrently validated our absolute measurements, but only compared the results 
of NIRS blood flow calibrations with literature.  By concurrently measuring 
resting blood flow with both methods during the same venous occlusions we 
could remove procedural, temporal, and subject population variables from 
consideration and directly validate our optical methods.  Methods employed here 
would make one of the few studies to comprehensively document muscle 
microvascular blood flow, limb blood flow, muscle blood oxygen saturation, as 
well as the derived metabolic parameter of oxygen consumption rate, 
continuously during dynamic exercise.   
4.1.1 Subjects and Measurement Setup 
 
10 subjects (2 females, 8males) were recruited and were all generally young 
with a mean age of 28 ± 2.8 yrs and without any known medical conditions.  
None were taking medication for any cardiovascular disorder.  Subjects were all 
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active, engaging in activity multiple times per week but none were involved in 
regularly strenuous exercise regimens and none had participated in any exercise 
the day of the measurement.  Subjects were recruited on a voluntary basis from a 
pool of healthy individuals and agreed to be measured via signed University of 
Kentucky Internal Review Board (IRB) approved consent forms.   
The subjects were positioned in supine with head supported by a pillow and 
right arm supported at heart level, for the measurement of systemic pressure/pulse 
via finger cuff plethysmography.  A finger plethysmograph (the same used in 
Chapter 3.3) was secured to the middle digit and used to monitor mean arterial 
pressure and pulse rate during the exercise protocol. Supine posture was used to 
more directly compare our data to other studies that, predominantly, used supine 
postures[13, 31, 54, 65].  Velcro straps secured the foot to the plate and the 
elevation of the dynamometer head was then raised to slightly above heart level.  
An inflatable thigh cuff (Zimmer ATS 1000, Indiana) was secured around the 
thigh above the knee firmly but without squeezing the leg.  This cuff was then 
primed with a brief inflation.  This served to set the tourniquet, fixing its position 
and decreasing the time to inflation during later occlusions.   
Tissue hemodynamics were collected by using the FD-NIRS/DCS hybrid 
optical device.  As described in Chapter 2.1 a commercial Imagent NIRS oximeter 
was used to acquire tissue oxygenation data and DCS was used to obtain rBF, 
from which the derived parameter (relative changes in oxygen consumption rate) 
could be calculated. The hybrid DCS/Imagent flow oximeter probe (Figure 20) 
was attached to the medial gastrocnemius of the test leg, after sterilizing both the 
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probe site and probe pad with alcohol preps.  Adipose tissue thickness (ATT) was 
measured at the probe site before attaching the probe using a manual caliper 
(Lange 85300, Texas) three times consecutively and the result averaged to 
produce a determination of the optical barrier.    
Figure 20. Hybrid Optical Probe 
The hybrid optical probe consisting of a modified Imagent ISS optical probe. The silicone block 
had holes punched to accommodate the bundled 2-wavelength (785 and 853 nm) DCS source 
fibers and the 5 bundled single mode DCS detector fibers. This silicone rubber is 1cm thick and 
black which makes it an excellent shield to external noise, as well as having sufficient pliability to 
conform to the curves of human limbs and thus make good contact. 
The optical probe pad was secured to the medial gastrocnemius with clear thin 
film adhesive dressing (Tegaderm, 3M, St. Paul, Minnesota) or two 6 inch strips 
of surgical tape one placed along axis of the muscle and the other in the 
circumferential direction (with care not to compress the muscle only to apply 
enough force to secure the optical probe).  The strain gauge was placed just above 
the probe pad, underneath the tape layer and in the “shadow” of the pad such that 
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tape did not grab the strain gauge or pull on it which would induce artifact; this 
was easily verifiable by observing the strain gauge signal during final application 
of tape.  Signal sensitivity of the strain gauge plethysmograph (Hokanson E-4 
Strain Gauge Plethysmograph, Bellevue WA) was set to 1%.  The device was 
then electronically calibrated and zeroed to the subject’s resting limb 
circumference.  Strain gauge signals were recorded via a visual basic program and 
written to a text file with the computer time stamped to assist in alignment of data 
with DCS data.  Sampling of analog signals from an AD board was set at 1 KHz 
and 200 data points were then averaged to produce a final sampling rate of 5 Hz.  
This data was read into MATLAB for processing along with the DCS/Imagent 
data.  Once the probe was secured, the optical fibers were taped to the bed to 
remove their weight from the probe and reduce negative pressure on the muscle 
belly.  The signal was then tested and the probe pad readjusted, if necessary, in 
order to maximize signal integrity. Upon completion of the instrumentation set up 
(~5 minutes) a calibration protocol was performed.  The entire experimental 
layout is demonstrated in Figure 21. 
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Figure 21. Equipment and Exercise Protocol Set-up 
 (1) DCS/ISS Hybrid Equipment; separate control computers connected via TTL link and receive 
analog position input from dynamometer to gate data collection during exercise.  Total sampling 
rate (consisting of alternating between DCS acquisition and Imagent acquisition) is 1 Hz.  (2) 
Optical probe sited over medial gastrocnemius at location of the muscle belly.  (3) Occlusion cuff 
secured above the thigh for inducing venous occlusion and arterial occlusion for calibrations.  (4) 
Strain gauge and control computer run independently and concurrently during both calibration and 
exercise protocols.  Sampling rate set at 100 Hz with an average of 50 data points per recorded 
data point for overall data collection of 0.5 Hz.  (5) Dynamometer is used to control exercise 
workload and frequency via setting 30% MVIC resistance and passive return to rest.  A visual 
metronome is used to regulate subject timing.  
4.1.2 Calibration Protocols for Absolute Hemodynamic Measurements 
The calibration protocol consisted initially of a 3minute resting baseline 
measurement.  Following that, a series of calibrating occlusions was performed.  
These consisted of three, 10-second, 50 mmHg, venous occlusions (VOs) with 1-
minute of recovery between each occlusion.  The change in THC during each VO 
was approximated by a linear fit and then averaged to produce the mean change in 
tissue compartment blood volume.  This volume change, in units of μMol/kg/min, 
was converted to the perfusion units commonly used to describe tissue blood flow 
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as previously described (Chapter 2.3).  These same VOs were used to compute the 
limb blood flow based on the increase in strain gauge resistance caused by 
volume increases during the occlusion.  Concurrent strain gauge blood flow 
values were used to cross validate initial blood flow calibration.  Next a single, 3-
minute, 250-mmHg, arterial occlusion (AO) was performed wherein the fitted 
slope of the difference between [HbO2] and [Hb] during the first minute provided 
the baseline muscle tissue oxygen consumption rate measurement, as described in 
Chapter 2.4.  Following the AO, 5 minutes of recorded recovery allowed 
affirmation that the subjects’ hemodynamics had returned to baseline values.  The 
calibration protocols required ~15-minutes in total to complete and its 
organization summarized by Figure 22.  
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Figure 22. Absolute Hemodynamic Calibration and 30%MVIC 
Dynamic Plantar Flexion Protocol Layout 
The above diagram summarizes duration and timing for each procedure.  The black dotted box 
signifies the period in which the gating algorithm is active, and thus the sampling rate reduces to 
0.5 Hz.  Otherwise overall data sampling rates are 1 Hz as has been discussed. 
The FD-NIRS Imagent collected data using a sampling rate of ~7 Hz to 
capture 5 data points ([Hb], [HbO2], THC, and StO2) per second to increase the 
temporal resolution of the hemoglobin concentration measurements and promote 
optical sensitivity to the calibration occlusions.  Afterward DCS flow data 
(sampled for 300 ms) collected a single rBF data point.  The overall sampling rate 
for both devices was 1 Hz.  DCS and Imagent data collection was controlled by 
TTL signals to protect the integrity of each optical signal.  
Following the calibration protocols, data collection was halted and the 
calibration data file saved, after which the subject’s maximal voluntary isometric 
contraction (MVIC) load was determined.  This procedure was used to normalize 
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exercise load to a percentage of each subject’s maximal strength thus attempted to 
remove subject strength/fitness as a variable.  The MVIC test consists of three to 
five, 5-second, isometric (static plate) contractions with three consecutive 
plateaued work outputs.  The average of these values is used to determine the 
maximum force generation for each subject’s plantar flexor muscles.  The plantar 
flexion resistance was set as 30% of the MVIC and the subject was allowed to rest 
while the instrument settings and data file for the exercise protocol were prepared.  
Following the MVIC determination subjects were given a brief (5-6 cycles) 
exercise training to familiarize them with the exercise protocol to be performed. 
Subjects were given at least 5 minutes of recovery between MVIC test and 
exercise baseline measurement while investigators saved calibration data files and 
adjusted optical instrument data collection to exercise regime.   
4.1.3 Gastrocnemius Hemodynamic Assessment During 30% MVIC 
Dynamic Plantar Flexion Exercise 
 
 
After taking 3 minutes of baseline data to reconfirm measurement stability, 
subjects then performed 3 minutes of 0.5 Hz, 30% MVIC, full range of motion 
(15-30°) plantar flexion exercise.  Exercise rhythm was preserved by use of a 
visual metronome and examiner prompting, in order to keep the duty cycles as 
consistent as possible.  Each duty cycle consisted of a 0.5-second contraction, a 
0.5-second relaxation to rest position, and a 1-second passive rest following the 
contraction/relaxation phases.  Data collection was limited to this one second rest 
phase by the use of a gating algorithm (see Chapter 2.5).  Immediately upon 
reaching the end of contractions, a single 50 mmHg VO was performed to assess 
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post exercise limb flow via SGVP.  Fifteen minutes of post exercise recovery 
hemodynamics were measured to assess long term muscle metabolic/flow 
responses to rigorous exercise.  Refer to Figure 22 to review the overall protocol 
layout. 
  During exercise protocols the FD-NIRS data collection regime was adjusted 
to 7 waveform averages per data point (300 ms total sampling time) and the 
measurement ratio set 1 to 1 with the DCS flow measurements.  This decreased 
the temporal resolution of hemoglobin concentration measurements but increased 
sampling time for a single data point, thus increasing the signal-to-noise ratio of 
these measurements for more accurate determination of hemoglobin concentration 
and V̇O2 changes.  DCS was set to a correlation/sampling time of 600 ms for a 
single data point and thus the total sampling rate for the protocol was 1 Hz, except 
where this 1-second of data was gated to collect between 1-second duty cycles, 
reducing overall sampling rate to 0.5 Hz during exercise. 
File markers were used to indicate time points for the beginning and ending of 
exercise for offline data analysis.  During the experiment, the DCS and Imagent 
operating programs displayed, on their respective screens, the online relative flow 
index, absolute hemoglobin concentrations, and tissue oxygen saturation.  The 
calibrated blood flow and derived oxygen consumption rate were calculated via 
offline analysis using MATLAB processing code.  Data from the Imagent, DCS, 
and finger plethysmography were co-registered using file marker time stamps so 
that all data from the three devices could be aligned precisely. 
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4.2 Gastrocnemius Translation and Hemodynamic Profile Results 
4.2.1  Subject Demographics and Calibrated Baseline Values 
Exercise strength normalization with MVIC produced comparable working 
loads that were a mean of 28.1 Nm.  Pre-measurement ATT was normal for all 
subjects and did not pose substantial optical barrier.  All subjects were able to 
complete the protocol and initial values (see Table 7) indicate healthy resting 
values for controls. 
Table 7. Subject Demographics and Measured Resting Baseline 
Values 
Subject Demographics and 
Key Protocol Values  
Mean±Std 
Age (yrs) 28±3 
ATT (mm) 6.4±1.5 
MVIC (Nm)  93.7±26.5  
Mean Power (W) 13.5±3.4  
Baseline StO2 (%) 72.6±3.0  
Baseline Optical BF 
(ml/100g/min)  
Baseline SG BF 
(ml/100g/min) 
0.88±0.4; Optical 
1.13±0.6; Strain Gage 
Individual data were shown for a single subject (Subject 4) in Figures 23-25 
during calibration.  Values were obtained for the resting conditions for flow and 
oxygen consumption rate from our calibration protocols of venous occlusions and 
arterial occlusion.  Characteristic trends included the rBF dramatically decreasing 
during AO, the slight decreasing in rBF during VO, and the hyperemic overshoot 
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following AO of about 225%.  Clear desaturation and separation of Hb/HbO2 
indicated successful V̇O2 calibration.  THC trends closely mirrored those of the 
strain gauge as demonstrated in figures 25 and 26; these calculated blood flows 
were demonstrated to be simultaneous by time axis examination (Figures 23 and 
24).  All values returned to baseline levels following five minute recovery 
periods.   
Group mean calibration was consistent with individual subject data for all 
parameters.  Cross validation of initial absolute blood flow was successful during 
baselines.   A correlation R2 = 0.51 for mean individual absolute NIRS blood flow 
and SGVP blood flow was observed (Figure 26).  Mean initial blood flow for 
muscle tissue was comparable but significantly lower than limb blood flow 
measured by the strain gauge (Table 8).  However, limb blood flow was observed 
to only be an average of 1.3X greater than local blood flow in contrast to the 2-3X 
previously reported in literature[12, 13, 65].  Repeatability for each occlusion was 
good with mean strain gauge measurements having a standard error of 0.63 ml 
blood/100ml tissue/min and with NIRS occlusions having a standard error of 0.35 
ml/100ml tissue/min (Table 8).    Baseline values for NIRS blood flow 
measurements agreed well with literature values, finding a wide range from 0.35 
to 1.36ml/100ml tissue/min (Table 8) [14, 17, 31, 61, 63, 65].  The strain gauge 
values were lower than most literature, ranging from 0.4 to 2.4ml/100ml 
tissue/min (Table 8)[27, 64, 85, 86].  V̇O2 measurements are likely underestimates 
with a mean 0.049 mlO2/100ml/min.  However the range of 0.023 to 0.127 
mlO2/100ml/min measurements agree with literature reports finding values of 
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around 0.02 to 0.15 mlO2/100ml/min, with a typical mean of 0.1 
mlO2/100ml/min[12, 14, 31, 61, 63].   This might be related to the known arterial 
leakage that occurs even when using 50+mmHg of pressure over systolic 
pressure.  The small influx of oxyhemoglobin depresses the decrease occurring 
due to occlusion and makes the [HbO2-Hb] difference smaller, thus the 
underestimate.   
Table 8. Subject Initial Absolute Calibration Values 
 VO Calibrated 
Optical BF 
(ml/100ml/min) 
VO Calibrated  
SG BF 
(ml/100ml/min) 
AO Calibrated 
V̇O2 
(mlO2/100g/min) 
Subject 1 1.04±0.06 1.18±0.05 0.009 
Subject 2 1.36±0.11 2.40±0.07 0.127 
Subject 3 1.33±0.06 1.94±0.15 0.023 
Subject 4 0.61±0.13 1.29±0.08 0.057 
Subject 5 0.62±0.16 1.03±0.06 0.030 
Subject 6 0.35±0.16 0.57±0.09 0.036 
Subject 7 1.03±0.35 0.46±0.16 0.058 
Subject 8 0.46±0.01 0.41±0.03 0.027 
Subject 9 0.95±0.35 1.04±0.10 0.059 
Subject 10 1.07±0.32 1.01±0.06 0.068 
Mean±std 0.88±0.35 1.13±0.63 0.049±0.033 
Each flow value is shown as the mean ± std of three VO flows.  V̇O2 is shown as a single AO 
measurement only.  Group means are presented as mean ± standard error.   
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Figure 23. Sample Subject (Subject 4) Hemodynamics and 
Strain Gauge Data During Calibration Protocol 
Descending order: Deoxy, Oxy, and total hemoglobin concentrations, StO2, rBF (with raw data in 
blue, filtered in green), and strain gauge data at bottom.  Hemoglobin trends, oxygen saturation, 
and rBF trends indicate successful occlusion;  rBF decreases during VO supporting the assertion 
that these pressures do in fact decrease flow to the limb[27]. 
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Figure 24. Zoom-in Sample Subject (Subject 4) Optical THC and 
Strain Gauge Data During VO 
Volume changes measured by both strain gauge(bottom) and NIRS(top) concurrently, indicate that 
the effects of the VO upon vasculature are immediate and detectable by both systems.  Correlation 
of individual VO volume changes between the two methods resulted in R2 values of 0.93, 0.88 and 
0.98 respectively.  These correlations decreased once the conversion factors to acquire perfusion 
units were applied suggesting a disconnect between the set of assumptions used to calculate local 
tissue perfusion and limb volume changes assumed to equal flow.  Black lines are the plotted 
linear fits of each occlusion. 
 
 
Figure 25. Zoom-in Sample Subject (Subject 4) V̇O2 Calculation 
During AO 
 Rapid decrease in oxygenated hemoglobin and simultaneous increase in deoxygenated 
hemoglobin causes the difference to approach zero during the occlusion period.  This rate is 
estimated via MATLAB polyfit and produces a slope (shown in black dotted lines) which may be 
converted from units of μMolO2/min to units of mlO2/100g tissue/min.  Note the initial increase is 
likely due to the cuff taking time to reach fully occlusive pressures.  Only the first minute of 
occlusion is necessary to obtain an estimate of oxygen consumption rate, the remainder is used to 
assess the overall quality of the occlusion. 
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Figure 26. Correlation Curve for Baseline Absolute Blood Flow  
Between NIRS and Strain Gauge Plethysmography 
A correlation of R2 = 0.51 was obtained which indicates a sound correlation between the two 
parameters despite high degrees of intersubject variation and differences between limb and muscle 
flow (to which the remainder of variance is attributed).  Strain gauge measurements are generally 
higher than optical methods as has been noted by most NIRS flowmetry groups.  On average the 
difference was local blood flow measurements by the optical device was 78% lower than strain 
gauge measurements.   
 
4.2.2 Gastrocnemius Hemodynamic Profiles During Exercise  
 
Individual data for the same subject (Subject 4) are presented in Figure 27 to 
illustrate typical individual hemodynamic profiles during the exercise protocol.  
Exercise baseline data for hemodynamic parameters were stable.  This subject, as 
is typical, shows clear initial changes due to exercise including decrease in THC 
caused by muscular compression of the compartment.  StO2 decreases sharply 
while rBF increases rapidly, contributing to the substantial rV̇O2 increase.  At 
onset of exercise these values changed rapidly and a plateau was achieved within 
about two minutes of exercise with significant increases of ~350% rBF and 
~600% rV̇O2.  Absolute optical BF was 2.4 ml/100mltissue/min while SGVP 
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measurements resulted in 3.1 ml/100mltissue/min, reasons why SGVP blood flow 
are larger than NIRS are discussed in chapter 4.3.2 and the appendix.  Neither 
parameter recovered completely 15 minutes post exercise, remaining significantly 
elevated by approximately 2 fold compared to baseline.   Tissue desaturated 
significantly to 55% from an initial 70%, recovering to sustained super baseline 
levels following exercise.  Subject pulse rate and MAP increased to 90 BPM and 
105 mmHg respectively with end recovery pulse rate recovering completely (not 
significantly different from baseline) while MAP remained elevated, similarly to 
rBF, at 95 mmHg at the end of data collection.  Strain gauge signal was stable 
except during exercise where noise was substantial due to muscle contractions 
changing limb volume (Figure 27). The post-exercise VO is observable in 
hemoglobin (with increases in THC) and strain gauge (increased volume) data 
indicating a successful occlusion. 
  Group mean results were similar in trend to those of individual data, as seen 
in Figure 28 and Table 9. All the following changes were significant (p < 0.05) 
compared to baseline. Tissue desaturated by a mean of 13.4% compared to 
baseline (71.1 to 57.7%) while both local hemodynamics and systemic 
cardiovasculature rose rapidly.  All of these were indicative of substantial effort 
on the part of the subject population.  Recovery was rapid but incomplete with all 
parameters except pulse rate being significantly greater than baseline, a response 
that has been observed elsewhere[87]. Mean BF increased from 0.91 to 1.87 
ml/100mltissue/min (220%) while V̇O2 increased from 0.05 to 0.17 
mlO2/100gtissue/min (326%).  Strain gauge mean BF increased from 1.13 to 5.13 
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ml/100mltissue/min (454%) with a large standard deviation of 3.15 (standard 
error 1.1) ml/100mltissue/min due to subjects having a range from 2.5 to 12.8 
ml/100mltissue/min.  This data was then regarded as unstable, as discussed in 
chapter 4.2.2 and the appendix.  MAP and pulse rate increased from 77.9 mmHg 
and 63.5 BPM to 91.9 mmHg and 82.7 BPM respectively.  The majority of 
recovery occurred within the first minute following end of exercise as can be seen 
by observing the end exercise, 1-minute recovery, and end-recovery values, as 
well as time series data (Figures 27 and 28; Table 9).  
Consistency between subject responses to the protocol resulted in minimal 
temporal blurring of the rapid onset and end exercise trends, along with fairly 
small standard errors.  The VO used to assess end exercise flow via strain gauge 
may be observed in the individual subject data (Figure 27, hemoglobin) but was 
not evident during the group mean response (Figure 28, hemoglobin).  The 
interference with hemodynamics during this period was less than the variation 
that occurred between subjects responding to the same stimulus.     
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Figure 27. Sample Subject (Subject 4) Exercise Protocol 
Hemodynamic Response and Strain Gauge Data 
Descending order: Hb, HbO2, THC, StO2 and coaxial rBF and rV̇O2, followed by systemic pulse 
rate and MAP, and lastly strain gauge limb volume changes.  Exercise periods are marked by the 
first two vertical lines, the second of which also indicates the time of post exercise VO initiation.  
The third vertical line indicates the end of VO and beginning of recovery.    
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Figure 28.  Group Mean (n=10) Hemodynamic Profile for 
Gastrocnemius Muscle During Exercise 
Mean responses (with standard error bars) show clear effects of exercise, both locally and 
systemically.  Strain gauge BF relative increases are much greater than DCS flow and have 
standard error of 85% which could not be shown in this figure.  
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Table 9. Summary Values for Blood Flow, Oxygen Consumption 
Rate, and Systemic Parameters 
Blood flow data represents both local (rBF/BF) and strain gauge (SGBF) blood flows. Reported as 
mean  ± standard error.  * denote statistical difference (p < 0.05) from baseline values as 
determined by t-test, # represents statistical difference from end-exercise values by the same test 
and level of significance, and ^ denote significance between 1-minute recovery and end-recovery 
values.
Hemodynamic 
Parameter  
Initial 
Calibration   
Baseline 
Exercise 
End Exercise  1Minute 
Recovery 
End Recovery 
rBF (%) 102.1±7.6  100.9±2.9 220.4±9.5 * 144.0±4.4*#  158.7±4.3 *# ^ 
BF 
(ml/100ml/min) 
0.88±0.4 0.91±0.03 1.87±09 * 1.39±0.04*#  1.53±0.05*#^  
SGBF 
(ml/100ml/min) 
1.13±0.6 n/a 5.13±1.0* n/a  n/a  
rV̇O2 (%) 99.6±1.7 103.7±1.5 326.9±15.5*  164.6±6.8*#  145.1±3.8 *#^ 
V̇O2 
(mlO2/100g/min) 
0.05±0.03  0.05±0.01 0.17±0.01 * 0.07±0.02 *#  0.08±0.01*#^ 
StO2 (%)  71.1±0.9 72.6±0.1 57.7±1.7 * 68.5±0.8*#  74.4±0.8 *#^ 
MAP (mmHg) n/a 77.9±0.5 91.9±5.1* 83.2±0.2 *#  84.8±0.2 *#^ 
Pulse Rate 
(BPM) 
n/a 63.5±0.3 82.7±0.2* 69.3±0.5*# 62.0±0.4* # ^ 
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4.3 Gastrocnemius Translation and Exercise Hemodynamics Discussion 
4.3.1 Calibration of Absolute Measurement and Cross Validation with 
Strain Gauge 
The use of VO to calibrate DCS flow indexes is based on the presumption that 
resting blood flow is proportional to the diffusive motion of erythrocytes in tissue.  
By assuming a relatively steady state resting blood flow, the initial normalized 
value of αDB (100% of a 30-sec mean) is ascribed a perfusion value equal to the 
calculated arterial inflow via the VO protocol.  For such a calibration to be 
trustworthy, one must have some guarantee that the measurement protocol is 
stable and that the vasculature is in a truly resting state.  It is also important that 
the VO not induce large changes in local or systemic hemodynamics.  This 
assumption is borne out experimentally with local effects observed to recover 
within one minute following the venous occlusion [14, 22, 28, 32].  
For oxygen consumption rate calibration via arterial occlusion there are also 
several underlying conditions which are required for validity of the measurement.  
The first is that, generally speaking, since the venous compartment hold the 
greatest volume of blood, oxygenation values reflect a weighting toward the 
oxygenation of hemoglobin located in the post capillary vessels[29].  This 
distribution is not allowed to change or the compartment ratio of venous to 
arterial blood (γ, review chapter 2.4) may change and this alters the calculation of 
oxygen extraction.  The NIRS measurement of tissue StO2 is then safely assumed 
to represent muscle tissue O2 saturation following oxygen extraction.  This 
assumption is what allows investigators to use arterial saturation and tissue 
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saturation to make an artio-venous difference relation necessary for the 
calculation.  Microvascular blood flow is not as simple as entry, residence, and 
outflow, however, as the system (depending on physiological necessity) is capable 
of shunting the capillary beds or recirculating blood.  However, the spatial 
averaging of chromophore concentrations by NIRS results in overall tissue O2 
saturation that is insensitive to such behaviors.  The second major assumption is 
that once the pressure cuff reaches full pressure, the blood inside the compartment 
is theoretically isolated and therefore THC should remain constant, while any loss 
of saturation is due to consumption by the tissue.  In practice it is observed that 
this is not strictly so, but is true enough to be valid for short durations[12, 14, 20, 
61, 63].   
NIRS oximetry in general contains a confounding variable in muscle tissue 
due to the presence of the spectrally identical, single O2 binding chromophore 
myoglobin.  Myoglobin effects on NIRS oximetry is discussed heavily elsewhere 
but suffice it to say that the much higher oxygen binding affinity of myoglobin 
and myoglobin containing a single oxygen binding site limits the influence of 
myoglobin desaturation to detected signals.  Only once desaturation had reached a 
sufficient point to decrease the tissue blood bound O2 to myoglobin bound O2 to 
somewhat extreme levels[15,23,28,29].   
Calibration protocols were successful in producing venous occlusions and 
arterial occlusions that could be used to calibrate the relative blood flow and 
oxygen consumption rate measurements made during the exercise protocol.  
Initial blood flow measurements within each individual were consistent for each 
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VO but varied widely between subjects. Such variability has been noted 
throughout literature documenting blood flow and comes as no surprise to us[12, 
63, 65, 84, 88, 89].  Despite the variations we found good agreement with 
literature in both reported trends and actual values of calibration blood flow as 
well as in other hemodynamic parameters (Figures 26 and 28, Tables 8 and 9) 
Initial values for hemoglobin concentration, oxygen saturation, oxygen 
consumption rate, blood flow, etc. were all well within normal physiological 
norms[12-14, 17, 31, 54, 61, 63, 83].  Cross validation of our local optical flow 
measurements with more global limb blood flow obtained via SGVP proved 
successful with there being a good correlation between mean baseline flow values 
obtained using the two methods (Figure 26).  This agreement was lost in post 
exercise strain gauge measurements, due largely to the great standard deviation 
between subject blood flow responses to exercise with regards to both local and 
limb measurements of flow (Figure 28, Table 9).  Thus our aim of cross validating 
DCS calibrated flow against strain gauge flow is met under resting conditions but 
not during exercise.   
There exists a possible systematic underestimate of V̇O2 that is related to 
arterial leakage during arterial occlusions.  Some subjects experience a small 
increase in THC which can be attributed to an oxyhemoglobin concentration that 
is not decreasing as rapidly as deoxyhemoglobin increases.  Such microvascular 
leak would decrease the slope of ([HbO2]-[Hb]) and thus the V̇O2 would be 
underestimated, (see Figures 23 and 26).  The VOs measured by strain gauge and 
NIRS produced very similar and highly correlated changes in volume (Table 8).  
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Local effects due to the occlusion series were transient and fully recovered within 
5 minutes of recovery and with little drift between calibration and the initial 
baseline for exercise (Figure 23 and Figure 27, Table 9).  Minimal local 
hemodynamic effects following this calibration protocol are a necessity to its use 
since we cannot risk deviating the initial physiological conditions from baseline 
prior to a measurement.  This is to reduce the risk of  weakening our ability to 
distinguish exercise responses from unintended perturbation of the system during 
calibration and MVIC tests.   
The 5-minute minimum time between calibration/MVIC protocols and 
beginning of baseline for exercise is used to reduce such possibility.  This time 
was deemed satisfactory given that prior investigations used 5-minute resting 
periods between AO and exercise protocols or sometimes trials between 
exercises[17, 31, 65]. 
The primary objective of this study however was to transfer the techniques 
previously applied to the forearm to the lower limb muscles[20].  This included 
ensuring that skin fold thickness and penetration depth were such that we could 
get adequate signal.  This proved to be the case with all subjects having ATTs 
measuring less than 8 mm, most of which were closer to 7 mm, which places the 
superficial muscle layer well within the ~13 mm envelope of a 2.5 cm S-D 
separation set up[10, 32, 72, 90].   
One parameter which possessed a potent influence was subject posture.  The 
lower perfusion pressure of the supine posture produced a substantially greater 
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effort for subjects than did the sitting posture which has great implications on the 
ability of PAD patients to perform such protocols[90].  Our original intent was to 
perform seated protocols but changed to supine since there is a greater pool of 
literature available for this posture; most notably the study performed by Bauer et 
al in 2007 which had both PAD and age matched controls using a very similar 
measurement methodology to ours consisting of measuring oxygenation with a 
NIRS spectrometer during supine plantar flexion exercise protocols, but with the 
notable exception that they measured blood flow via post exercise SGVP venous 
occlusions[54].  This means that the Bauer study did not measure blood flow 
continuously and only measured muscle tissue oxygenation (StO2), not 
metabolism (V̇O2)[54]. Still the study served as a basis of comparison between 
our measurement/exercise methodology and that of already accepted techniques.  
However, future PAD study should use the seated posture to reduce the stress on 
compromised vasculature of patients and make the study more closely resemble a 
physiologically normal scenario (subjects will be more likely to be 
sitting/standing than fully reclined). 
4.3.2 Hemodynamic Profiles During Exercise 
Exercise results of this study proved fruitful in that the combined NIRS/DCS 
system, coupled with a finger plethysmograph, was able to capture a very broad 
range of hemodynamic parameters noninvasively and continuously during 
dynamic exercise.  The author is aware of no other studies that demonstrate such 
capability and this could mark the first noninvasive examination of absolute 
values for all of these parameters throughout such a protocol in the 
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gastrocnemius.  Mean subject hemodynamic and metabolic changes due to 
exercise parallels other similar study responses, see Table 10[13, 54, 65, 83, 84, 
88].  A broad range of values exists in literature for both BF and V̇O2 depending 
largely on how BF is measured. Such variation in methodology makes direct 
comparison of outcomes difficult but allows us to examine trends.  Of particular 
import is the apparent rapidity of microvascular increases in blood flow, oxygen 
consumption rate, tissue desaturation, as well as systemic responses.  All of these 
parameters increase dramatically within a few seconds of exercise and a full 
hemodynamic plateau is reached within two minutes of 30%MVIC plantar 
flexions.  Exercise data collection gating successfully removed motion artifacts 
during the protocol, preserving the quality of blood flow and metabolism optical 
data (see Chapter 2.5 for reminder of gating algorithm).  Post exercise changes are 
likewise very rapid, being mostly complete within the first minute and the system 
seems to impose a demand for high temporal resolution measurement methods 
(Figures 27 and 28, Table 9).  
The extent of absolute flow increase is more than 2 fold for most subjects, 
ranging from a 0.44 ml/100ml tissue/min minimal responder to 3.76 ml/100ml 
tissue/min.  However, absolute resting baseline is not correlated with the 
magnitude of exercise as some subjects with the highest initial absolute blood 
flow had only mediocre relative increase (130-160%).  Relative increases in V̇O2
are about 100% greater than those of BF and this is in line with literature reported 
increases of oxygen extraction for metabolically stressed muscle[16, 54, 84, 88].  
Initial mean V̇O2 was found to be 0.06 mlO2/100g tissue/min on average with 
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ranges from 0.01 to 0.14 mlO2/100g tissue/min and typically increased much 
more (100%) than BF from 0.02 to 0.39 mlO2/100g tissue/min, a pattern typical 
for fatiguing exercise[31, 64, 65, 88].  Oxygen saturation exhibited, for the most 
part, a substantial decrease, falling from initial 2-minute means of 70-75% to end 
exercise plateaus of 55-50%.  These response time courses and extents are 
comparable to those of other similar studies using NIRS to measure oxygenation 
[54, 84, 88].  The variation of response is not unusual for exercise and accents the 
necessity for large subject populations in these kinds of studies. 
Table 10. Comparison of Baseline and Exercise Values from Literature 
*Data presented as mean ± std, ** data presented as mean ± std error, ^ data presented as figure
(extrapolated from data but not explicitly stated in text).  Due to the complexity and variety of 
Study Methods for 
Measuring BF, 
VȮ2 
Resting BF 
(ml/100ml/min) 
Exercise BF 
(ml/100ml/min) 
Resting V̇O2
(ml O2/100g/min) 
Exercise V̇O2
(ml O2/100g/min)
Henry 2014,  NIRS VO; 
SGVP,      
NIRS AO 
(n = 10) 
0.88 ± 0.4;  
1.13 ± 0.6 
1.87 ± 09; 
5.13 ± 1.0 
0.05 ± 0.03 0.17 ± 0.01 
^Baur 2007 
[54] 
SGVP,  (n=8) ~3 ~26 
**Boushel 
2000 [64] 
SGVP,         
NIRS/SGVP, 
(n=7) 
2.6 ± 0.3 44 ± 7 
0.23 ± 0.07 6.6 ± 1 
*Casavola
2000 [14] 
NIRS VO, 
multiple 
measures on 
single subject 
0.40 ± 0.10 
0.04 ± 0.02 
*Van
Beekvelt 
2001 [65] 
NIRS VO; 
SGVP,         
NIRS AO; 
NIRS SGVP, 
(n=26) 
0.9 ± 0.45; 
2.06 ± 0.70 
0.11 ± 0.02; 
0.15 ± 0.06 
^Kooijman 
1997 [13] 
NIRS VO,
NIRS AO, 
(n=15) 
0.68          
(0.54-0.97) 
1.36           
(1.12-1.64) 
0.02           
(0.01-0.03) 
0.04           
(0.02-0.05) 
^Egena 2005 
[89] 
SGVP,  (n=12) ~3 ~18 
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these studies a “;” is used to indicate two methods of measuring a single parameter (reported top 
first bottom second) and a “,”  used to indicate the separation of parameters measured. 
Strain gauge plethysmography BF measurements, with end exercise values 
ranging from 2.5 ml/100ml tissue/min (2X mean baseline) to 12.8 ml/100ml 
tissue/min (12X mean baseline), were of much greater variance than local optical 
measurements; end-exercise data show 270% (SGVP) mean standard deviation 
compared to 30% (DCS) mean standard deviation.  The extreme variation of 
SGVP end-exercise values and issues related to the methodology lead us to 
conclude that SGVP should only be used to evaluate limb resting flow and cannot 
be used to accurately assess the behavior of local microvasculature.  There could 
be a nonlinear relation between local muscle blood flow and whole limb blood 
flow.  Indeed, the two should not be expected to have a strictly linear relation as 
the factors that govern microvascular flow are different in many ways than those 
that govern whole limb flow[13, 26, 27, 85].  Examples of this include the 
sympathetic vasoconstriction of vascular beds in non working muscles while 
working muscles vasodilate. Whole limb and working muscle blood flow may 
increase but microvascular flow in the non working muscles is decreased.  Such 
difference in methodology, observed wide variances for end exercise strain gauge 
BF, and a lack of correlation with end exercise rBF, as well as the necessary 
temporal delay between end of exercise and VO, makes end exercise blood flow 
measurements by strain gauge non optimal.   
Few studies make extended measurements of recovery periods following 
exercise and those that do rarely report this data as time series.  Such omission 
makes it difficult to assess the pattern of hemodynamic recovery following 
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metabolic challenge.  Our data show a very pronounced post exercise increase in 
most parameters.  The only parameter to reach pre exercise values significantly 
was pulse rate.  MAP, BF, V̇O2, and StO2 all remained elevated throughout 
recovery (see Chapter 4.2.2).  Sustained significant flow elevation post exercise is 
typical of rigorously exerted non athletic subjects and agrees with the results 
found in the few studies that included a prolonged recovery measurement of blood 
flow[84, 88, 91].  From this it can be definitively concluded that recovery from a 
strenuous exercise protocol can be quite prolonged in the muscle tissue.   
These results highlight the importance of the previous baseline shift study as 
this time period would be highly susceptible to the influence of a gradual shift in 
blood flow (which would also affect the derived oxygen consumption rate).  
Furthermore, the increases found during the baseline study were of approximately 
the same magnitude and time course as the post exercise effects meaning that the 
two would be indistinguishable from each other had we not taken steps to 
alleviate the probe pad influence.   
Total Hemoglobin concentration sharply decreased at the onset of contraction.  
This decrease seems to be more predominant in oxyhemoglobin than 
deoxyhemoglobin producing a steep desaturation curve that is consistent with 
other literature[54, 84].  If the initial contraction of the muscle causes a shift in 
overall hemoglobin distribution of the muscle that is not resolved before 
observation during the resting periods then there may be a change in γ (see 
chapter 2.4) for which it is necessary to account[16, 17, 54, 92].  Previously our 
lab had calculated that this change should be small enough to not present a 
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significant effect and could be ignored, with this view being also supported by 
literature [16, 92]. 
4.4  Gastrocnemius Translation Study Conclusions 
Techniques developed by previous studies in the forearm were successfully 
translated to measurement of the lower limb, with attention to posture, contraction 
frequency, calibrating occlusions, and attachment of the optical probe.  Success in 
calibration was evidenced by having obtained baseline absolute values for BF and 
V̇O2 that were comparable to those found in previous studies (see Tables 9 and 
10).  Cross validation of NIRS VO BF measurements at rest with SGVP was 
positive with SGVP BF being comparable in magnitude and correlated to optical 
values.  This agreement was lost during exercise.  Data were of good quality with 
fairly low variance (mean standard deviation of 30%, compared to over 200% 
changes in relative values for BF and V̇O2 at end exercise, the most unstable 
period) for subjects indicating that attachment protocols and data gating during 
exercise were functioning as intended.   
Exercise protocols successfully induced physiological challenge in healthy 
control subjects and measurements during exercise were free of motion artifact 
due to implementation of a gating algorithm produced previously[20].  These 
exercise trends were also of similar profile to those of similar exercise studies, 
inasmuch as our continuous optical DCS measurements can be compared to 
profiles using SGVP and Doppler ultrasound to assess flow.  Oxygenation data 
clearly agree with tissue saturation profiles in literature demonstrating the 
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effectiveness of this exercise protocol to induce challenge of the muscle. Systemic 
cardiovascular response also suggested effectiveness in challenging subjects and 
induction of whole body response to lower leg exercise, making this protocol a 
sound investigation of exercising hemodynamic response in healthy subjects. 
Overall, we have generated a ready pool of data for young healthy control 
subjects against which we can compare future studies, satisfying both of the 
primary objectives of this study.  Using these methods we may begin 
investigation into PAD subject populations. 
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CHAPTER 5:  PAD PILOT INVESTIGATION OF HEMODYNAMIC 
RESPONSE IN COMPROMISED VASCULATURE  
The aim of this pilot study was to explore the feasibility of the calibration 
and exercise methods discussed in Chapter 4 to a small population of PAD 
patients, as well as healthy control subjects.    PAD in particular, being a 
perfusion disorder, stands out as being a disease about which our technology may 
be able to provide clinically relevant data.  By using the calibration and 
dynamometer gated exercise protocol we may be able to assess local 
hemodynamic, metabolic, and systemic cardiovascular response differences in 
PAD patients as compared to healthy ones.  But in order to pursue this research it 
was first necessary to test a small sample group and identify possible problems or 
inadequacies in our instrumentation/methodology.  Toward this end we measured 
2 patients, of different levels of claudication (one resting pain, one activity 
induced ischemia), and 3 healthy subjects using the protocol outlined in chapters 
4.1.2 and 4.1.3, with the modification of using a sitting posture.  This sitting 
posture is less hemodynamically demanding and so was judged to offer less 
chance of patients having an ischemic attack during the protocol and failing to 
complete it, or being unduly pained  (which presents both ethical and 
physiological variability challenges).   
5.1 PAD Pilot Experimental Protocols 
In order to provide significant metabolic challenge to the lower extremity 
muscle tissue and vasculature, for the purpose of determining the functionality of 
such under stress, we decided to perform a sub-maximal plantar flexion exercise 
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protocol.  The protocol was to be performed by a small pilot population of two 
PAD patients (recruited via collaboration with vascular surgeon Dr. Eleftherios 
Xenos, of the Kentucky Clinic) and three healthy control subjects.  Subjects were 
recruited on volunteer basis gave consent, after being informed of the protocol to 
be performed, on approved IRB consent forms.  Three control ages were 26, 35, 
54years, while PAD patients were of similar ages, at 62 and 64.  Patient ages were 
comparable to the ages (64 ± 3 PAD) listed in Bauer et al 2007[54].  Healthy 
control subjects were taking no known medications for cardiovascular disorders 
and had no known health conditions before the protocol was started but one 
healthy control subject (aged 35) did appear to have pre-hypertension.  Both PAD 
patients were hypertensive but did not notify us as to any treatment medications 
such as vasodilators or diuretics.  PAD Patient 1 was wearing a compression boot 
on his left (most claudicant) leg and reported resting pain in this leg, while the 
other patient had no pain at rest.  This indicated that Patient 1 was in a more 
advanced disease state than Patient 2.     
Preliminary clinical tests performed during assessment for treatment 
demonstrated notable differences between patients using similar continuous wave 
Doppler with segmental pressure exams, with the notable difference that one 
patient (patient 2) underwent a treadmill walking test (4 minutes, 2 mph, 12% 
incline).  The ankle/brachial pressure index (ABI) is used to assess the degree of 
claudication in patients by determining the relative decrease in pressure in the 
lower limb as compared to the contra-lateral upper limb (ABI= Pankel/Pbrachial).  
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Generally, the scores greater than 0.95 to 1 indicate a healthy un-occluded limb 
while scores of less than 0.9 indicate increasing levels of claudication.  
PAD patients were to be delivered to the test room via wheelchair to prevent 
claudicating symptoms and muscle fatigue before the protocol began.  
Subjects/patients were then asked to sit in an adjustable chair with their feet in a 
dependent (declined) position, as opposed to elevated, in order to increase 
perfusion pressure in the lower legs (comparing Figures 22 and 30)[90].  The 
instrumentation, optical probe, and data collection/processing were the same as 
those used to assess healthy control hemodynamics during the translation study 
detailed in Chapter 4.1, as were the baseline absolute hemodynamic calibrations 
(Chapter 4.1.2) and exercise protocols (Chapter 4.1.3) used for inducing 
hemodynamic challenge in this study.   The entire protocol set up is illustrated in 
Figure 29.  
Resting relative blood flow during calibration occlusions was not saved for 
healthy subjects, online data was used to evaluate successful occlusions for these 
3 healthy subjects but was later recorded for PAD patients to better evaluate 
occlusion success and is now standard practice for all protocols. 
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a)   b)
Figure 29. PAD Pilot Measurement Set-up and Probe/Leg 
Position 
Figure 29a shows a full protocol set up during calibration phase.  After calibration and MVIC test 
a finger plethysmograph is placed on the right hand middle digit to record systemic parameters.  
The device can cause bluing of the finger and mild discomfort over time and so is not used 
during calibration.  1) shows the placement of the optical probe (viewed more closely in figure 
20) over the medial gastrocnemius muscle belly.  ATT are taken from this same location.  2) 
Shows the hybrid FD-NIRS/DCS optical system.  The operating systems for both devices are on 
separate computers and are controlled separately except for TTL signaling during data collection.  
3) This is the dynamometer head and footplate which controls the subject work output during 
exercise, just off-screen is the dynamometer operation screen (at patient’s eye level) which 
contains the visual metronome and protocol control settings. 4) The occlusion thigh cuff is shown 
here in its typical placement, again in a closer view in Figure 29b, as is the optical probe. 
5.2 PAD Pilot Protocol Results 
5.2.1 Hemodynamic Profiles During Calibration Occlusion Protocols 
Resting ABIs were within normal limits with patient 1 having a 1.23 (left) and 
1.2 (right) score while patient 2 had a 1.0 (left) and 0.92 (right) score.  Patients 
were deemed by this examination to be lacking evidence of significant arterial 
occlusive disease at rest.  The treadmill test revealed patient 2 to have non-
recovering scores of 0.3 (severely occlusive) for both legs and indicated 
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significant arterial occlusive disease and substantial insufficiency with exercise.  
Given the patient histories of diabetes and high blood pressure the high normal 
scores for patient 1 are indicative of arterial hardening and incompressible 
vasculature typical of diffusive PAD.  Thus the resting ABI test should always be 
accompanied by an exercise test for PAD examination to rule out false positives 
caused by such contributing disease states. 
Table 11. Subject Demographics and Resting Optical Baseline 
Values 
Subject Demographics and 
Key Protocol Values  
Healthy Control PAD Patients 
Age (yrs)  35,  54,  26 62,  65 
Skin Fold Thickness (mm) 6.5,  6,  7.5 8, 7.5 
MVIC (N∙m)  91,  53,  72  19,  45 
Mean Power (W) 13.7,  8.0, 10.7  2.9,  6.8 
Baseline StO2 (%) 70,  65, 68  55,  60 
Baseline Optical BF 
(ml/100g/min)  
0.43,  0.74,  0.51 0.07,  0.36 
With only 3 controls and 2 patients’ data, not age matched, conclusions are 
based on and emphasize observed trends; this data is not definitive and should 
only be considered from the perspective of showing the potential of hybrid diffuse 
spectroscopy to observe the healthy and patient population trends.  MVIC for 
healthy subjects was generally greater than patients, with corresponding powers 
of exercise being higher.  This suggests that there is a strength gap between 
healthy subjects and PAD patients but without more subjects this is a highly 
preliminary assessment.   
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The calibration protocol for healthy controls proceeded normally and was 
consistent in trend for all subjects (illustrated in Figure 30).  Individual values for 
initial blood flow and oxygen consumption rate varied widely but were within 
ranges of previous studies, at 0.43 to 0.74 ml/100ml tissue/min for blood flow and 
0.015 to 0.11 mlO2/100g /min for oxygen consumption rate and no artifact was 
noted during the occlusions/fitting estimates (Figures 30 and 31, Table 12).  Note 
that rBF for healthy controls during calibration were not recorded.  The success of 
the occlusions is demonstrated by normal increases in THC during VO, and 
mostly stable THC during AO accompanied by divergent Hb (increase) and HbO2 
(decrease) as seen in Figure 30.   
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Figure 30. Calibration Hemoglobin Time Courses for Healthy 
Control Subjects 
Descending order: Deoxy, Oxy, and THC, and StO2.  Occlusion periods are shown by arrows (to 
account for slight differences in occlusion time periods) with small arrows representing VO, and 
large arrows the AO.   
Figure 31. Sample Healthy Control Subject Occlusions with 
Calculated Resting Blood Flow and Oxygen Consumption Rate 
VOs (top panel) were largely consistent and produce a physiologically normal resting muscle 
blood flow. Success of the arterial occlusion is observed in the immediate decrease in [HbO2] 
compared to [Hb] and the typical oxygen consumption rate value calculated.  
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PAD patient calibrations were met with mixed success.  While venous 
occlusions and initial blood flow measurements seemed to be successful, no 
absolute V̇O2 values are available for PAD subjects.  This is due to arterial 
occlusions being unsuccessful in these subjects, as can be observed both by the 
hemoglobin concentration (non diverging [Hb] and [HbO2]) and by the additional 
observation of non zero relative blood flow during occlusion (Figures 32 and 33,).  
Initial oxygen saturation values for healthy subjects ranged from 65 to 70% 
compared to PAD patients who had saturations of 60% and 55% at rest (Figure 30 
and Figure 32, Table 11).  PAD patient resting blood oxygen saturations were 
lower than all healthy controls.  The resting oxygen saturation of PAD patients are 
comparable to the end arterial occlusion values of the healthy controls, suggesting 
that resting patient muscle is in a substantially hypoxic environment (Figure 30 
and Figure 32).  Neither patients’ hemoglobin nor oxygen saturation values 
returned to rest within 5 minute recovery periods, indicating an observable lack of 
recovery in PAD patients compared to healthy controls.  Calibration BF values for 
healthy subjects ranged from 0.74 to 0.43 ml/100ml tissue/min, while patients had 
widely different values of 0.07 and 0.36 ml/100ml tissue/min, both of which were 
values lower than even the smallest of the healthy control values. 
111 
Figure 32. Calibration Hemoglobin Time Course for PAD 
Patients 
Descending Order: [Hb], [HbO2], and THC, StO2, and rBF.  Vertical lines denote three VOs, 
followed by a single AO time period.  Subjects’ responses to occlusion were markedly different, 
with Subject 1 possessing a highly muted blood flow and lower resting oxygen saturation than 
Subject 2.  Neither subject could produce a successful arterial occlusion, as indicated by the 
oxygenated and total hemoglobin responses (second and third panel from the top).  250 mmHg 
pressure was used in Subject 2 AO but Subject 1 could not withstand this pressure (due to pain). 
rBF data show that rBF in Subject 1 is not greatly affected by this pressure (250 mmHg).   
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Figure 33. Sample PAD Patient Occlusions with Calculated 
Resting Blood Flow and Oxygen consumption rate 
VOs (top panel) were successfully performed and with reasonable outcome.  The AO (marked by 
vertical lines) displays a notable delay from onset of occlusion to apparent decrease in difference 
between HbO2 and Hb.  This is evidently due to the inability to fully restrict arterial inflow (see 
Figure 33) which causes a large underestimate of oxygen consumption rate despite relatively 
normal (low) blood flow.  This calculated oxygen consumption rate value is not deemed to be 
acceptable for use in estimating resting tissue metabolism. 
5.2.2 Hemodynamic Profile During 30% MVIC Plantar Flexion Protocols 
 Lacking a robust statistical relevance in this data set, individual data are 
presented and time series trends/mean values are presented, for the sake of this 
pilot study.  A note on results from the first PAD patient should be made in that 
the subject was unable to maintain the correct rhythm initially and thus data were 
initially unstable during exercise (as indicated by large deviations) until coached 
into the correct rhythm for the appropriate duration of exercise at the 0.5Hz 
frequency.   
Hemoglobin concentration changes differ between the groups with PAD 
patients exhibiting a muted change in all hemoglobin concentrations compared to 
healthy control subjects.  All subjects exhibited an initial increase in oxygen 
saturation at the onset of exercise and this is observable to be related to the initial 
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clearance of [Hb] compared to desaturation of [HbO2] (Figures 34 and 35).  This 
trend has been observed in other studies under similar conditions[31, 54].  The 
observed hemoglobin time course is consistent with previous results for plantar 
flexion exercise (Chapter 4).   
Exercise values (see Table 12) for healthy controls were generally robust, 
increasing a mean (787.4%, 609.5%, and 219.9% respectively from baseline.   
These healthy profiles followed the same trend observed in Chapter 4 healthy 
control exercise of rapid initial increase, plateau, and rapid decrease following the 
end of exercise (see Figure 34).  PAD patients demonstrated sharply different 
responses from one another with the claudicant patient rBF increasing by a mean 
216% while the less severe patient rBF increased to a mean 710% (Figure 35, 
Table 13).  rV̇O2 values were different in trend between healthy and patient 
populations, with mean exercise rV̇O2 being typically lower than mean exercise 
rBF (89.8% higher, 125.9% lower, and 51.5% lower) for control subjects 1 
through 3 respectively (Table 12).  PAD patients had mean exercise rV̇O2 values 
that were only 5.0% lower (in the resting claudicant patient 1) and 26.4% lower 
(in the mild PAD patient 2) than end exercise rBF (Table 13). This suggested a 
larger increase in oxygen extraction for those PAD subjects with a lesser blood 
flow.  Absolute blood flow seemed to be greater in most of healthy controls (3.88, 
5.34, and 1.69 ml/100ml tissue/min) than in patients (0.14 and 2.56 ml/100ml 
tissue/min).  Particularly notable was the difference between the claudicant PAD 
patient profile and the rest of the subjects (Figures 34 and 35, Tables 12 and 13).  
Oxygen saturation trends were greatly divergent however with healthy subjects 
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exhibiting desaturation during exercise while patients possessed very little 
change, even increasing during exercise (Figure 34 and 35).   
Recovery was incomplete for most subjects in all parameters except pulse rate, 
which tended to not be significantly different from baseline (Table 12 and 13).  
The 1st minute and 15 minute recovery values were calculated and indicated rapid 
recovery but a sustained super baseline level for both local parameters and 
systemic MAP persists, similarly to the results of chapter 4 protocols.  
The systemic data (pulse rate and MAP) for both populations show a response 
with a trend of increase during exercise.  MAP data is, however, notably unstable 
(see Figure 35) for both patients, which may indicate some plethysmograph 
instrumentation errors.  The two patients are clinically hypertensive as is one of 
the control subjects (as defined by a resting MAP >105).  These data are not 
stable or consistent enough on which to base any sound conclusions, given the 
instability in the instrument for observation of the PAD patients.      
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Figure 34. Healthy Control Subject Hemodynamic Profiles 
During Dynamic Exercise 
Descending order: [Hb], [HbO2], and THC, StO2, rBF and rV̇O2 coaxially, pulse rate, and MAP.  
Exercise periods are denoted with a black arrow.  Note here that the oxy saturation increases at 
onset of exercise before decreasing, in contrast to the slight increase followed by plateau of PAD 
subjects. 
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Figure 35. PAD Subject Hemodynamic Profiles During Dynamic 
Exercise 
Descending order: [Hb], [HbO2], and THC, StO2, rBF and rV̇O2 coaxially, pulse rate, and MAP.  
Exercise periods are denoted with a dotted black arrow for subject 1(due to inability to retain 
correct rhythm, initially) and solid for the second patient.  Data shown are the filtered individual 
time series, filtration is done as previously described.  Of note is the apparent lack of decrease in 
oxygen saturation and lack of separation between relative blood flow and oxygen consumption 
rate curves.     
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Table 12. Summary for Healthy Control Subject  
Hemodynamic Values 
Time Period Mean Control 1 Control 2 Control 3  
Baseline rBF (%) 106.3±30.8 99.9±33.8 106.7±49.7  
Baseline BF 
(ml/100ml/min) 
0.46±0.13 0.75±0.25 0.55±0.26  
Baseline rV̇O2 (%) 111.9±32.0 75.0±25.3 108.6±51.2  
Baseline V̇O2 
(mlO2/100g/min)  
0.045±0.013 0.015±0.005 0.098±0.046  
Baseline MAP (mmHg) 119.2±1.0 84.6±2.6 92.0±3.8  
Baseline Pulse (BPM) 60.4±0.9 68.0±2.2 60.2±0.9  
End Exercise rBF (%) 893.7±121.8* 709.4±201.9* 326.6±102.1*  
End Exercise BF 
(ml/100ml/min)  
3.88±0.53* 5.34±1.52* 1.69±0.53*  
End Exercise rV̇O2 (%) 983.5±146.6* 583.5±165.3* 275.4±86.5*  
End Exercise V̇O2 
(mlO2/100g/min) 
0.393±0.059* 0.117±0.033* 0.248±0.078*  
End Exercise MAP 
(mmHg)  
129.6±0.4* 96.8±0.3* 106.5±4.0*  
End Exercise Pulse 
(BPM) 
63.7±0.5* 66.3±0.6* 72.2±0.8*  
Recovery 1 min rBF (%) 398.7±260.7*# 239.7±177.4*# 160.5±62.0*#  
Recovery 1 min BF 
(ml/100ml/min) 
1.73±1.13*# 1.80±1.34*# 0.83±0.30*#  
Recovery 1 min rV̇O2 
(%) 
444.0±293.9*# 201.8±147.8*# 143.3±58.3*#  
Recovery 1 min V̇O2 
(mlO2/100g/min) 
0.178±0.118*# 0.040±0.030*# 0.129±0.053*#  
Recovery 1 min MAP 
(mmHg) 
123.9±1.97*# 95.1±0.7*# 94.2±3.6*#  
Recovery 1 min Pulse 
(BPM)  
61.1±1.9*# 65.2±0.2*# 64.0±3.9*#  
End Recovery rBF (%) 101.5±37.1# 145.3±46.3*# 134.9±50.9*#  
End Recovery BF 
(ml/100ml/min) 
0.44±0.16# 1.09±0.35*# 0.70±0.26*#  
End Recovery rV̇O2 (%) 107.2±39.1# 103.6±32.9*# 136.1±51.1*#  
End Recovery V̇O2 
(mlO2/100g/min) 
0.042±0.016# 0.021±0.007*# 0.123±0.046*#  
End Recovery MAP 
(mmHg) 
131.0±1.5*# 88.0±2.4*# 94.3±0.9*#  
End Recovery Pulse 
(BPM) 
64.2±0.4*# 67.1±2.0* 59.2±0.4*#  
Data presented as mean ± std for each individual.  These were calculated from 3 mins baseline 
data (150 frames), the final minute of exercise data (20-30frames), the first minute of recovery 
data (50 frames), and the final minute of recovery data (50 frames).  Significance (p < 0.05) is 
represented by * for comparing against baseline, and # for significance from end exercise.  Raw 
time series data were selected according to data frame time stamps to ensure accurate time points. 
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Table 13. Summary for PAD Patient Hemodynamic Values  
Time Period Mean PAD 1 PAD 2  
Baseline rBF (%) 112.4±50.7 106.4±37.3  
Baseline BF (ml/100ml/min) 0.07±0.03 0.38±0.13  
Baseline rV̇O2 (%) 111.2±49.9 107.5.0±37.9  
Baseline MAP (mmHg) 97.9±5.2 88.7±5.9  
Baseline Pulse (BPM) 74.3±2.0 57.0±1.6  
End Exercise rBF (% 215.7±143.3* 709.7±219.7*  
End Exercise BF 
(ml/100ml/min) 
0.14±0.09* 2.56±0.79*  
End Exercise rV̇O2 (%) 210.7±144.0* 683.3±208.3*  
End Exercise MAP (mmHg) 115.9±0.7* 110.2±1.6*  
End Exercise Pulse (BPM) 73.5±0.3* 64.9±0.3*  
Recovery 1 min rBF (%)  136.5.7±132.9*# 165.0±155.5*#  
Recovery1min BF 
(ml/100ml/min) 
0.09±0.09*# 0.60±0.56*#  
Recovery 1 min rV̇O2 (%) 132.7±128.6*# 165.5±155.0*#  
Recovery 1 min MAP (mmHg) 113.9±0.6*# 91.6±6.8*#  
Recovery 1 min Pulse (BPM) 72.8±1.0*# 58.4±2.7*#  
End Recovery rBF (%) 98.6±37.1# 151.0±74.9*#  
End Recovery BF 
(ml/100ml/min) 
0.06±0.04# 0.54±0.27*#  
End Recovery rV̇O2 (%) 103.5±69.7# 146.8±72.8*#  
End Recovery MAP (mmHg) 116.0±1.1* 102.6±2.1*#  
End Recovery Pulse (BPM) 74.0±0.8# 56.4±0.8*#  
Data are presented as mean ± std for each individual.  These were calculated from 3-minute 
baseline data, the final minute of exercise data, the first minute of recovery data, and the final 
minute of recovery data.  Significance (p < 0.05) is represented by * for comparing against 
baseline, and # for significance from end exercise.  Raw time series data were selected according 
to data frame time stamps to ensure accurate time points.  Due to failure to adequately occlude the 
limb V̇O2 could not be determined for these patients. 
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5.3 PAD Pilot Protocol Discussion 
5.3.1 Calibration Protocol 
The results of this pilot indicate that there seems to be a combination of factors 
involved with PAD.  The most obvious parameter is the reduced resting oxygen 
saturation.  The baseline oxygen saturation measured in these two subjects was 
below or near those reached during the end of 3 minutes arterial occlusion or at 
the end of exercise for healthy control subjects (see Table 11, Figure 30 and 
Figure 32).  This disparity clearly indicates that PAD is an ischemic condition, 
which is supported by most PAD literature [3, 13, 55, 93].  The ability of NIRS 
instrumentation to observe difference in baseline oxygen saturation is a positive 
sign for future studies being able to discern possible PAD tissue perfusion effects 
at rest. 
Optical venous occlusion measurements were able to calibrate initial blood 
flow for the DCS instrument in both healthy and patient subjects.  The patients, 
particularly the resting claudicant, had lower baseline BF than healthy subjects. 
We were unable to calibrate our rV̇O2 measurements in PAD patients since we 
could not successfully induce a total AO in either subject.  The claudicant patient 
was unable to tolerate arterial occlusion pressures due to claudication pain.  The 
second patient, even at 250 mmHg, could not sufficiently be occluded (see Figure 
32) as to be able to assume an isolated compartment.  As a result, both patients 
exhibited marked arterial leakage (Figures 32 and 33) which invalidated the 
calibration occlusion.  Given the sensitive nature of later stage PAD patients and 
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the likelihood that some future studies may attempt comparisons between pre and 
post operative patients to assess successful reperfusion surgery, AO calibration 
may not be feasible within this subject population.  However, our recent studies 
have shown that using a VO protocol can also estimate oxygen consumption rate, 
which will be explored in PAD patients in the future[94, 95].    
Baseline and calibration occlusion trends for absolute hemoglobin and relative 
blood flow were observable for all subjects using the methods outlined in 4.1.2 
and these were similar to those results found in chapter 4.2.1.  Despite observable 
indications that there may be a different StO2 trend during recovery from AO we 
cannot say that such difference is positively confirmed, nevertheless the trends for 
oxygen saturation between the two PAD subjects were consistent between each 
other and are suggestive of tissue oxygenation effects due to PAD being possibly 
quantifiable by NIRS spectroscopy.   
Depressed tissue saturation and muscle strength is indicative of compromised 
function in the gastrocnemius microvasculature for these patients.  The PAD 
patients we measured, especially the resting claudicant, were substantially weaker 
than controls.  Without more subjects no generalizations may be made about 
control and patient populations strength however, and some literature indicates 
that there may be no difference in strength for mild PAD[54].  It should be noted 
that since healthy controls were not age matched the effect of age on all these 
parameters cannot be evaluated and age matching would be paramount to 
establish in a full scale study with MVIC used as a possible regression parameter 
for predicting BF/V̇O2 response to exercise.   
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5.3.2 Exercise Protocol 
Following trends in previous studies, individual responses varied widely 
between individuals but in the case of this protocol the responses were much more 
robust for healthy controls.  The large increases in rBF found in these subjects 
(including both healthy subjects and a patient) compared to Chapter 4 responses 
may indicate that postural perfusion pressure may be more potent than previously 
assumed.  As expected, the resting claudicant subject was unable to greatly 
increase flow and appeared to fatigue before the end of the protocol as the 
exercise flow response could not be maintained throughout the protocol.  While 
this exercise intensity may be applicable in the seated position, it would likely 
prove too strenuous for severely claudicant patients or for patients measured in 
supine.     
The apparent increase in oxygen saturation at the onset of exercise is likely 
attributable to a fluid shift since THC, HbO2, and Hb decrease initially but Hb is 
preferentially removed indicating venous clearance by the muscle contraction, a 
similar trend is observed in forearm data reported by our lab[20].  The lack of 
desaturation and overall hemoglobin profile in these subjects is different from that 
observed in Chapter 4 protocols and requires more data to be conclusive but does 
demonstrate potential for observing differential responses to exercise onset. 
Relative oxygen consumption rate trends closely follow those of relative blood 
flow for healthy controls indicating that these subjects have a flow dominated 
increase in oxygen consumption rate as opposed to an extraction dominated one.  
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These responses, at least for healthy control subjects, are in contrast to the 
Chapter 4 protocol results in that V̇O2 nearly uniformly increased much more than 
BF as would be expected of a metabolically challenging protocol. These 
responses were consistent among patients with most subjects having an rV̇O2 
unexpectedly close to rBF, but more data is required before this observation can 
be assumed to apply to the general population. The ability to monitor both flow 
and oxygen metabolism in comparison to one another may prove to be a potent 
tool in determination of possible PAD effects on muscle oxygen utilization.    
Pressure responses were similar to previous protocols in that there was a 
distinct increase in MAP during the protocol and a decrease to a super baseline 
pressure throughout the recovery period.  Pulse rates are also consistent with 
previous protocol results, recovering completely.  Systemic parameters were not 
greatly different compared to healthy controls, indeed the blood pressure profiles 
were more similar than initially assumed and would not explain the differences in 
exercise responses observed.  Pulse rate and MAP were clearly elevated for all 
subjects during exercise, except the claudicant who could not generate enough 
effort to stimulate pulse rate response. 
5.4 PAD Pilot Protocol Conclusions 
Important for the purposes of this pilot, all subjects could complete the 
majority of the protocols with the exception of arterial occlusions which require 
re-evaluation for employment/stability in patient populations and may possibly be 
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replaced by a venous occlusion protocol to calibrate resting oxygen consumption 
rate.   
Systemic and local hemodynamic profiles were generally in line with those 
observed in supine healthy control exercise protocols sharing rapid changes at 
onset/end of exercise with sustained hemodynamic elevation persisting 
throughout the 15-minute recovery period, with the exception of the oxygenation 
data discussed above.  Of particular interest, it was found that there seemed to be 
a different trend of response in healthy control hemodynamics while sitting 
compared to supine.  This might be due to the difference in hemodynamic 
environments from supine to sitting posture and so much more data is required to 
be able to draw meaningful comparisons between healthy control responses in 
sitting vs. supine subjects let alone disease populations against healthy ones.  
With such a small subject size we cannot verify the generality of these responses 
but the overall similarity with previous studies and broadness of the 
hemodynamic data that we were able to obtain is promising.   
Overall, this pilot was successful in demonstrating the potential of a hybrid 
flow/oximeter in observing and quantifying local muscle hemodynamics.  The 
protocol methodology proved mostly sound and was repeatable for 5 subjects.  
While some questions pertaining to calibration, postural effects, and finger 
plethysmograph reliability must be resolved the hybrid diffuse optical methods 
and overall protocol design are ready for refinement to begin a broader set of 
experiments.  Future studies, with greater numbers of subjects may more 
rigorously assess PAD hemodynamic responses based on these findings.  Lastly, 
124 
 
the normal range of ABI test values for the patients at rest clearly indicates need 
for alternative means of detecting claudication and determining patient muscular 
microvascular health. For the purposes of more clearly defining disease status in 
future patient populations it would be preferable to use walking tests for all 
patients to better ascertain the level of claudication of each patient.  These may 
then be used, in conjunction with our local measurements and exercise protocol, 
to better quantify disease progression and regress data on the basis of 
hemodynamic response versus clinical predictors.  
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CHAPTER 6:  LIMITATIONS, SUMMARY, AND PERSPECTIVES  
 
6.1 Limitations of Optical Spectroscopy and Measurement Methodology 
The limitations of diffuse optical techniques, particularly DCS, are 
predominantly related to the light penetration depth into the tissue.  Low power 
NIR light sources and single mode detection fibers make for a maximal tissue 
penetration depth of ~1.5 cm for DCS, depending on tissue absorbance and power 
delivery to the tissue[31, 44, 96]. NIRS allows for the use of larger multimode 
detector fibers and can collect oxygenation data in tissues up to ~3 cm deep[13, 
31, 59, 64, 65].  The current penetration depth of DCS allows for examination of 
the superficial skin and muscles but not deeper muscles and organs.  The use of 
bundled detector fibers greatly improves what signal we may obtain from these 
tissues, even at greater depths[31-33, 41, 59]. 
Related to penetration depth is the inability of (especially DCS) optical signal 
to reliably escape from large vessels.  The high absorber concentration (blood 
volume) of the veins and arteries means that optical probes positioned with large 
vessels in the photon diffusion path length experience greatly reduced signal 
amplitude resulting in the inability to correlate flow or determine tissue 
oxygenation through these vessels.  Probes should be positioned carefully to avoid 
optical paths through such vessels.  This disadvantage compensates by strictly 
limiting our observations to microvascular flow.  
Temporal resolution is dependent on correlation time, which is itself 
dependent on signal strength.  While each individual correlation curve calculation 
is very rapid (~20 Hz or 50 ms per curve), these curves must be averaged to 
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reduce noise[20, 33].  With low absorbance tissues (female muscle e.g., typically 
exhibits a much greater signal to noise ratio as compared to male muscle tissue) 
correlation averaging times may be decreased, increasing the ultimate sampling 
frequency.  Experimentally, it was general practice here for leg muscles to use 
sampling rates of 1-2 Hz, which when coupled with oximetry, resulted in an 
overall sampling rate of 1 Hz for every hemodynamic parameters (MAP, pulse 
rate, BF, [Hb], [HbO2], THC, StO2, V̇O2). 
The use of an optical probe secured directly to the tissue surface has its own 
problems.  Contact measurements are subject to introducing curvature errors due 
to the flattening of soft tissue underneath the optical probe[96].  Sharply curving 
surfaces, such as small limbs, alters the geometry of the probe/tissue interface 
and, in the case of small tissue volumes, may induce spatial violations of the 
semi-infinite boundary condition[96].  Contact probe pressure can also generate 
substantial hemodynamic response in resting baselines and during exercise.  The 
reasons for this are explored in detail in Chapter 3.   
Previously, a major limitation was that of motion artifacts.  Changes caused by 
motion may be observed in both NIRS oximetry and DCS, but DCS is influenced 
in a particular way that makes it more susceptible to artifact.  The ratio of 
dynamic to static scatterers (α) is assumed to remain constant during 
measurements reflecting at least short term stability in hematocrit.  It is this 
assumption that can lead to motion artifacts during measurements however.  
When non-blood related cells move, light is scattered by these additional dynamic 
scatterers e.g., muscle fibers and α is substantially increased.  This causes a 
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greatly overestimated flow index and its effects are noted in literature using DCS 
methodology to observe muscle systems[16, 20, 44, 83].  Much of this artifact can 
be avoided by careful protocol control and subject training.  The restriction of 
data collection to static phases of exercise allows a very near approximation to 
continuous observation without loss of important data.  
An exercise protocol specific problem was that it proved difficult for patients 
and new subjects to adjust to the exercise timing.  The pacing for contraction and 
rest are crucial to collecting stable data and difficulties in proper timing result in 
erratic data points (see PAD subject 1 exercise data, chapter 5.2.2).  Also, some 
questions arise as to how much MVIC tests and the familiarization period may 
impact baselines.  Extended responses to exercise indicate potential for elevation 
between calibrating occlusions and exercise baselines, thus it may be preferential 
to separate this procedure either by moving it to the start of the protocol and 
requiring 25 to 30 minutes before calibrating occlusions, or doing it on a separate 
day.     
One of the challenges of measuring exercise hemodynamics is the large (and 
widely documented) range of inter-patient variation.  We noted substantial 
differences in hemodynamic response even with strength normalization and age 
matching, and this indicates that large populations will be required to assess the 
diagnostic quality of these measurements.  Statistical analyses demonstrate that 
the results are more robust with 10 subjects providing a power of greater than 
80% for baseline mean comparisons, rest vs. end-exercise comparisons, and end-
recovery vs. baseline comparisons. rBF was used as a test variable for these 
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studies and the results of power analysis extrapolated onto the remaining 
variables, given the comparably large responses in these parameters with lesser 
variance. 
6.2 Summary of Research and Perspectives 
Initial research aims of my study were to adapt the hybrid diffuse optical 
techniques developed during previous examinations of forearm flexor muscles to 
the lower leg muscles (gastrocnemius) during dynamic exercise.  The intent for 
this was to open a line of research into diseases of the vasculature and assessing 
lower limb muscle tissue performance via hemodynamic and metabolic parameter 
profiles during exercise.   
Preliminary examinations and prior research indicated an unexpected baseline 
shift during contact measurements and these had to be rectified before satisfactory 
post exercise data collection or long duration protocols could be considered. 
Baseline evaluation studies confirmed and characterized the baseline shift and 
subsequent probe/protocol redesigns greatly stabilized the contact measurements.  
In addition to greatly decreasing the measurement effect on the muscle tissue the 
baseline studies confirmed the sensitivity of muscle microvasculature to 
circumferential applied pressure. The baseline flow increase agreed in trend with 
clinical assessments of the effectiveness of elastic bandaging for increasing 
perfusion in the limb, a common treatment for vascular insufficiency related 
disorders like PAD[69, 72, 73, 82].  By confirming the effectiveness of protocol 
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redesigns in both the forearm muscles and gastrocnemius we were able to proceed 
with lower limb studies. 
Translating hybrid NIRS/DCS exercise measurement methods to the lower 
limb involved first identifying accepted dynamic exercise protocols which could 
be used in conjunction with our equipment and which could be controlled for 
reproducibility.  Dynamometer based plantar flexion exercises were decided upon 
as was previously the case in forearm studies, for their commonality and for the 
great control over exercise motions and associated data collection via the 
dynamometer signaled positional gating algorithm developed previously.  We 
finally determined a comparable protocol which was in agreement with standard 
practices in physiological journals, applicable to patient populations, and allowed 
for optimal use of our NIRS spectroscopy[13, 18, 54, 61, 83, 84, 97].   
Using a concurrent strain gauge measurement, we cross-validated our absolute 
BF calibration by the optical technique during repeated VOs, finding correlation 
between the two measurements of baseline BF.  Healthy control subjects 
produced hemodynamic profiles during exercise which agreed with those in 
literature and against which we can compare future vascular/muscle disease 
studies[13,17,54,55,83].   
 Lastly, a pilot study was performed to explore the feasibility of using the 
calibrated hybrid spectroscopy and gated exercise protocol methodology for PAD 
patient studies.  The small population size, as mentioned previously, limits the 
amount of empirical conclusion that may be made based on this data but results 
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were promising.  The measurement methodology proved no more difficult to 
apply to patients than to healthy subjects and did not incur any medical risks 
towards the patients.  One flaw in the calibration protocol was that the arterial 
occlusion (but not venous) was unable to apply sufficient pressure, or such 
pressures induced pain and could not be applied, such that baseline absolute V̇O2 
could not be calibrated and only the relative change in this parameter could be 
observed during exercise.  Subsequent research by other lab members applied a 
similar method of calibrating both flow and oxygen consumption parameters with 
venous occlusions that remedies this shortcoming[94, 95].  
Exercise protocols produced continuous hemodynamic/metabolic profiles for 
both healthy control and patient groups and the results thereof indicate a 
promising line of research for investigation of PAD effects on muscle tissue.  By 
making use of the noninvasiveness, rapid sampling time, and continuous 
collection properties of hybrid diffuse optical flow-oximetry in muscle tissue 
during exercise the ability of the muscle to adapt/respond to metabolic stress can 
be assessed for long periods of time and during dynamic protocols. Application of 
these methods to future full-scale studies is likely to produce a unique 
investigation of muscle physiology and disease pathophysiology, but many more 
patients and healthy control subjects will be required to reach statistical and 
diagnostic relevance. 
In conclusion, the overall objectives of this research were successfully met in 
that we were able to refine our measurement stability for contact probe DCS-
Imagent hybrid spectroscopy on in-vivo muscle tissue and to extend the range of 
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calibrated, standard unit, absolute measurements to the lower limb musculature.  
We then obtained a consistent set of healthy control subject exercise responses, 
for a variety of measured parameters (and subsequent derived parameters), which 
could be used to monitor tissue hemodynamics/metabolic response to exercise 
stress.  Using such measurements as a basis of comparison, the initial steps were 
taken to begin investigation of muscular disease states and their effects on muscle 
tissue microvascular hemodynamics and metabolism at rest and during exercise. 
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Appendix 
 
Notes on Strain Gauge Plethysmography  
Strain gauge plethysmography has many documented faults as an approach to 
dynamic measurements since it can be greatly affected by fluid shifts typical of 
working limbs (bone flow, interstitial fluids etc.) but this group found that more 
than these theoretical flaws, implementing the strain gauge was difficult during 
exercise due to the need to precisely apply a low pressure to the limb to get a 
venous occlusion.  Despite limiting the movement of the limbs complete lack of 
motion is impossible and even small motions can loosen the pressure cuff (which 
must be applied so as to not induce enough passive pressure to cause baseline 
shift).  This means that achieving venous occlusion without disturbing the 
hemodynamics of the limb is difficult at best (and may explain the underestimate 
of our venous occlusion values) if done properly. 
Reasons for the possible underestimates in our strain gauge data are not 
certainly known but are suspected to lay elsewhere than the strain gauge itself and 
the recorded data as the sensitivity of the strain gauge to volume changes was 
very high and the variability between individual BF measurements during 
calibration quite low (mean standard deviation of 0.086).  Pressure considerations 
being what they were, we erred on the side of conservatism in applying the cuff 
and this could have produced incomplete venous occlusions which (due to rapid 
changes in hemoglobin post exercise) would be difficult to confirm using local 
NIRS measurements.  Post exercise VO can be observed in some subjects NIRS 
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data via data frame time stamps (as in Figure 27) but were not observable in 
enough cases to be correlated, and cannot be verified with the strain gauge itself.  
Literature reporting resting muscle blood flows as low as 0.9 to 1.1 ml/100ml 
tissue/min and as high 5 as have been observed using strain gauge 
plethysmography[98].  The large degree of variability in blood flows reported in 
literature from one study to the next suggests that there is a methodological or 
equipment induced variation between groups that introduces substantial difference 
in observed blood flow despite the procedure for strain gauge plethysmography 
being tested and accepted as reliable and individual groups reporting low variance 
within their respective studies.  Given that our blood flow values are within 
physiologically accepted ranges for resting blood flow and ranges reported by 
other groups we may assume that our strain gauge data are reliable at rest.  
Overall, strain gauge venous plethysmography can be considered a useful tool to 
assess blood flow in resting conditions but is, in this author’s experience, not 
trustworthy in dynamic measurements or for patient populations including 
elevated blood pressure conditions, which encompasses the PAD patient 
population, due to the increased mean pressures and often sclerotic vessels 
making occlusions very difficult to reliably achieve, without applying pressures in 
excess of those known to restrict vessel diameters[27].
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